Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	718	"lung: 664.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;NB-4: 10.4;SCLC-21H: 4.5;U-2197: 22.2"	"Cancer enriched"	"Detected in some"	218	"lung cancer: 226.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010928	Enhanced				"Secreted in other tissues"					"HPA010928: AB_1857425"		"unprognostic (1.84e-1)"			"unprognostic (1.96e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.13e-1)"	"unprognostic (2.97e-1)"		"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.32e-2)"		0.1	0.8	0.2	0.3	0.5	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.1	0.1	0.1	664.5	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	22.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.3	0.1	0.4	0.1	0.9	0.1
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560402	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	225	"lung: 501.0"	"Group enriched"	"Detected in some"	21	"BEWO: 6.3;NB-4: 6.6;RPMI-8226: 21.2;U-2197: 12.8"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"					"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: , HPA049368: AB_2680731"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	501.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.4	0.0	0.2	0.0	21.2	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	12.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	66	"lung: 411.8"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 30.0"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	63	"plasmacytoid DC: 6.2"	"Lineage enriched"	"Detected in single"	63	"dendritic cells: 6.2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"					"CAB016793: , HPA042638: AB_2678095, HPA045752: , HPA049368: AB_2680731"						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	411.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	30.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"gallbladder: 37.4;lung: 91.9;stomach 1: 126.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.1"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.7;stomach cancer: 186.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced									"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2.0	0.1	0.0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.5	0.4	0.9	0.4	1.4	0.7	0.5	0.2	0.2	0.0	0.1	0.7	0.5	0.0	0.2	0.5	1.8	0.0	1.0	0.4	0.1	0.6	0.1	2.5	0.1	0.2	0.1	3.1	1.1	0.6	0.6	0.7	0.0	0.0	0.3	0.2	0.4	1.9	0.6	2.0	0.4	1.5	0.2	0.0	0.3	1.0	0.3	0.4	0.6	0.0	0.3	0.7	0.4	0.3	1.0	1.7	1.3	0.4	2.0	0.1	0.0	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"		16	89195761-89201664	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	21	"brain: 39.3;lung: 50.7;pancreas: 69.7"	"Group enriched"	"Detected in some"	5	"BEWO: 23.2;Hep G2: 18.6;NB-4: 9.5;RPMI-8226: 11.2;THP-1: 6.1"	"Group enriched"	"Detected in many"	9	"liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4"	"Region enriched"	"Detected in some"	23	"cerebellum: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.71e-3)"	"unprognostic (2.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.89e-1)"	0.1	0.3	0.0	0.3	0.4	1.1	0.1	39.3	0.1	0.3	0.5	0.0	0.0	0.6	0.2	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	50.7	2.5	0.0	0.0	0.7	69.7	0.1	0.0	0.1	1.7	0.2	0.1	0.4	0.7	0.2	0.1	0.3	0.3	0.1	0.3	1.0	0.5	1.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	23.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	18.6	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.5	0.5	2.3	0.0	2.6	11.2	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	39.3	0.1	0.1	0.0	0.0	0.0	1.7	0.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"lung: 51.5;thyroid gland: 122.8"	"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 47.6"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.4;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.4;hypothalamus: 12.0"	"Group enriched"	"Detected in some"	13	"basal ganglia: 6.4;hypothalamus: 16.1"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	51.5	0.1	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	122.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	47.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.1	0.2	2.5	0.0	0.1	0.1	0.4
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"lung: 508.4"	"Cell line enriched"	"Detected in some"	69	"HaCaT: 207.4"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	17000000	17000000			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	28.7	0.0	0.1	0.0	0.1	0.0	0.0	508.4	0.0	0.1	0.0	9.4	0.2	0.0	7.4	0.0	0.1	7.6	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.3	4.8	0.1	0.1	0.0	0.8	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"lung: 757.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;NB-4: 5.5;U-2197: 11.2;U-266/70: 4.1"	"Group enriched"	"Detected in many"	149	"lung cancer: 1306.7;thyroid cancer: 270.2"	"Region enriched"	"Detected in single"	17	"pons and medulla: 2.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	71000000	71000000			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: "	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	757.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	1.1	1.4	2.6	4.1	0.8	1.5	1.2	0.2	0.4	0.4	0.8	0.5	0.9	4.8	0.4	0.3	0.1	0.1	0.5	1.0	0.1	0.4	0.1	3.2	0.4	0.1	0.1	0.6	0.4	0.5	1.1	0.4	0.1	0.2	2.4	0.0	0.5	0.3	0.2	0.0	0.4	0.8	0.2	0.5	1.7	5.5	2.6	0.7	2.1	0.4	0.5	0.3	0.5	0.7	0.5	0.1	0.8	0.3	0.6	0.4	0.1	0.3	1.0	11.2	0.2	4.1	0.8	0.3	1.0	0.7	0.2	0.9	2.5	0.8	0.9	4.1	0.7	1.0	1.0	0.8	1.4	1.1	1.4	0.8	2.6	0.8	2.5	0.7	1.5	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0
AC119676.1		ENSG00000284895			1	41585306-41628816	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 1.9;lung: 3.2;smooth muscle: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;ASC diff: 11.2;U-266/70: 1.7;WM-115: 2.8"									"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	1.3		0.0	0.0	0.0			0.0		0.0	0.0		1.9	0.7	0.0	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SFTA3	"NANCI, SFTPH"	ENSG00000229415	"Surfactant associated 3"	P0C7M3	14	36473288-36513829	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	16	"lung: 45.2;thyroid gland: 55.4"	"Cell line enriched"	"Detected in single"	195	"SCLC-21H: 21.0"	"Group enriched"	"Detected in some"	238	"lung cancer: 18.4;thyroid cancer: 52.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"													"prognostic favourable (8.29e-4)"				"unprognostic (3.95e-1)"				"unprognostic (3.21e-3)"		0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"lung: 24.2;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.2;SK-BR-3: 1.7;T-47d: 1.1;U-2197: 4.4"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534"	Uncertain									"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.1	4.4	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 70.3;lung: 87.0;stomach 1: 68.3"	"Cell line enriched"	"Detected in some"	18	"A549: 20.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 61.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"					"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	70.3	0.0	0.0		0.0	0.0	87.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in single"	7	"HEL: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.1"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	380000	380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favourable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353062-73354295	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 2.0;testis: 6.8"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.6"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA064505	Uncertain									"HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.0;Karpas-707: 3.7;MOLT-4: 4.0;U-266/70: 13.2;U-266/84: 5.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	29	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.2	5.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.3;MCF7: 4.5;RPTEC TERT1: 5.5;U-266/70: 6.6"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	140000	140000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favourable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.3	2.1	2.9	0.1	0.3	0.1	0.2	0.1	0.5	0.2	2.3	0.5	2.3	0.2	1.2	0.4	0.4	5.3	1.4	0.1	0.0	0.0	0.6	2.4	0.3	0.3	0.1	0.2	0.4	0.0	0.8	0.3	4.5	0.3	1.7	0.0	0.0	0.1	0.3	0.3	5.5	0.1	0.1	0.5	0.1	0.0	2.0	1.3	0.1	0.3	0.0	1.6	1.6	0.2	6.6	3.4	2.4	2.3	0.5	0.6	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	2100000	2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.3	11.3	6.8	20.3	16.9	10.4	9.6	2.5	3.0	1.1	12.7	18.6	10.2	1.6	5.4	2.0	1.0	2.1	1.7	7.3	2.9	12.5	0.7	3.5	12.9	8.5	8.1	2.6	10.0	2.2	2.1	5.6	1.7	0.5	1.0	0.8	2.6	1.1	3.3	4.9	9.0	0.7	0.8	3.3	14.6	0.8	3.3	0.9	2.0	12.7	2.7	6.0	6.5	6.0	1.0	0.6	0.2	5.3	2.7	7.5	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4"	"Group enriched"	"Detected in some"	6	"HL-60: 11.8;U-937: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.5"	"Group enriched"	"Detected in many"	38	"dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8"									HPA048515	Enhanced									"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favourable (9.33e-4)"	4.2	1.2	0.3	6.4	1.2	35.4	1.2	0.6	1.1	0.9	1.5	0.3	0.1	0.2	1.9	3.7	0.9	1.3	2.8	3.5	0.3	0.3	1.9	3.4	36.2	9.6	0.5	0.8	1.0	1.4	0.0	0.6	3.4	1.2	1.3	1.3	1.4	1.5	0.1	0.7	1.1	1.9	3.5	1.5	22.4	1.3	0.9	0.3	2.8	0.7	0.1	1.2	2.1	1.0	0.0	17.1	46.5	32.8	0.8	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	11.8	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	36.9	0.0	4.1	32.8	46.5	0.0	26.4	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.1	10.2	0.8	28.4	1.5	0.0	12.5	0.3	1.2	0.6	1.1	0.3	0.3	0.5	0.8	1.2	0.3
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"brain: 5.0;lung: 1.8"	"Cell line enriched"	"Detected in single"	5	"TIME: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8"	"Low region specificity"	"Detected in some"			HPA041641	Uncertain				"Secreted to extracellular matrix"					"HPA041641: AB_2677592"	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	1.8	0.0	0.2		0.0	0.0	0.1	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Group enriched"	"Detected in some"	6	"THP-1: 18.8;U-937: 58.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"									HPA014731	Enhanced									"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1, axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 15.4;lung: 28.7;retina: 49.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HDLM-2: 6.9;RPTEC TERT1: 14.2;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA042257	Enhanced									"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.3	0.1	15.4	0.0	0.1	0.1	0.1	3.6	0.1	28.7	0.0	0.1	0.0	3.9	0.1	0.0	0.6	0.3	0.1	0.1	0.0	49.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.3	0.6	1.7	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 248.0"	"Cell line enhanced"	"Detected in some"		"A-431: 22.4;EFO-21: 14.0;NTERA-2: 16.0;PC-3: 79.2"	"Cancer enriched"	"Detected in some"	10	"lung cancer: 211.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Cell type enriched"	"Detected in single"	40	"basophil: 30.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"						"unprognostic (3.85e-1)"	"unprognostic (1.77e-1)"			"unprognostic (2.99e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.84e-2)"		"unprognostic (3.17e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.90e-8)"	"unprognostic (9.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.11e-2)"	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	248.0	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.1	1.0	0.1	0.0	0.1	1.7	0.4	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.2	0.3	30.1	0.5	0.7	0.2	0.0	22.4	0.3	0.3	0.5	0.3	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.3	0.1	14.0	0.0	0.2	0.6	0.3	0.1	0.0	0.4	0.8	2.4	0.0	0.0	0.1	0.8	0.4	0.2	0.1	0.0	0.0	0.6	0.3	0.0	0.4	0.2	0.2	16.0	79.2	0.0	0.2	0.0	0.3	0.1	1.1	0.3	3.1	0.3	0.0	0.3	0.1	0.4	0.3	9.4	0.4	0.3	0.4	0.3	0.1	0.1	0.3	1.0	30.1	0.5	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.1
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"lung: 104.5"	"Group enriched"	"Detected in some"	5	"CACO-2: 13.5;CAPAN-2: 7.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.2	0.1	0.1	0.5	0.0	0.2	0.1	13.6	1.4	6.3	0.2	0.1	0.0	1.6	0.1	104.5	0.1	0.1	0.1	0.3	1.1	0.4	0.1	0.6	0.2	0.2	0.0	0.1	1.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	2.0	1.3	0.1	0.1	1.0	0.4	0.3	0.1	5.4	1.7	0.1	0.1	0.0	0.0	1.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	7.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	1.5	0.5	0.1	1.7	1.3	1.7	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA028338	Enhanced									"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.0;hTCEpi: 13.1;HUVEC TERT2: 12.6;SK-BR-3: 9.8"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB018654	Uncertain									"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.1	0.0	0.3	0.0	7.8	0.0	0.1	0.4	0.2	24.0	1.0	0.2	6.5	0.0	7.5	0.5	4.8	0.2	0.0	0.7	0.3	1.7	3.5	0.1	0.2	7.7	0.0	13.1	0.2	1.0	12.6	1.4	0.2	0.0	0.5	0.0	0.2	0.1	1.9	0.7	0.0	0.3	0.0	1.6	0.4	0.2	1.1	9.8	2.5	0.3	0.1	0.6	1.1	0.3	3.5	0.0	0.5	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362677-73364171	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;HMC-1: 1.5;NTERA-2: 2.1"	"Cancer enriched"	"Detected in single"	3155	"testis cancer: 254.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043699	Uncertain									"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.2	0.5	1.2	0.2	2.1	0.0	0.2	4.1	0.9	0.2	0.2	0.2	0.2	0.1	0.2	1.5	0.3	0.1	0.2	0.2	2.1	0.6	0.2	0.2	3.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.6	0.3	4.9	0.2	4.4	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.8	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	4.1	0.9	2.1	0.6	0.4	0.2	0.2	0.2
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.6;Hep G2: 14.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.6	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.8	14.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.3	0.0	0.1	1.0	0.0	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Cell line enhanced"	"Detected in some"		"HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"											"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002666: , HPA055244: AB_2682756"	"prognostic favourable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.4	0.0	48.8	27.5	0.0	0.0	0.0	0.0	0.0	17.1	13.4	0.1	0.0	18.9	12.2	0.0	0.0	17.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.9	7.2	0.0	34.8	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362799-50504244	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 86.1"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 64.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		1000000	1000000	Vesicles	Vesicles	"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.9	1.6	1.3	11.1	1.1	1.4	14.9	6.5	1.1	1.7	0.9	0.6	1.4	1.7	1.2	0.9	1.1	0.9	7.6	1.7	9.1	1.6	0.5	86.1	1.3	3.9	3.2	2.2	4.0	3.8	6.0	1.9	6.1	3.0	2.0	6.1	1.5	1.4	1.7	2.6	1.7	1.4	1.4	1.5	4.1	5.8	2.5	0.2	2.3	0.1	0.7	0.7	0.7	1.8	0.3	0.7	0.1	2.3	3.6	1.1	0.0	0.0	1.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	0.1	0.0	0.0	0.2	0.0	0.0	6.2	64.9	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.2	0.0	2.7	1.8	2.6	2.0	0.0	1.3	3.6	2.2	0.0	2.3	0.1	0.3	3.2	1.1	1.6	11.1	14.9	6.5	1.7	9.1	3.9	3.2	6.1	2.5
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112995-55173175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.4;T-47d: 3.3;U-87 MG: 1.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 0.4"					HPA053900	Uncertain									"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.1	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.3	3.3	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Cell line enriched"	"Detected in many"	7	"BJ hTERT+: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"					"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	288.7	2.6	8.5	0.0	0.9	0.0	39.6	0.0	3.4	0.0	0.0	41.2	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.6	0.2	8.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.4	0.0	0.0	0.0	22.9	1.2	0.0	0.0	0.1	0.0	3.9	0.0	0.3	22.2	4.1	0.3	1.1	3.7	0.0	0.0	0.1	18.6	2.1	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	"Plasma membrane"	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286967-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.1;bone marrow: 13.7;lung: 13.5"	"Cell line enhanced"	"Detected in some"		"HEL: 35.3;HMC-1: 8.9;K-562: 18.3;NB-4: 15.2;U-937: 8.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in many"	5	"non-classical monocyte: 53.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.1"														"Intracellular and membrane"																							1.9	0.4	0.4	1.6	0.4	13.7	0.6	0.2	2.0	1.0	2.9	0.2	0.0	1.1	1.1	2.9	2.3	1.1	1.1	1.1	0.5	0.3	1.6	1.7	13.5	3.3	0.4	0.0	1.2	0.4	0.1	0.4	1.9	2.4	2.4	0.5	0.9	2.5	2.7	1.7	0.8	1.4	0.2	0.9	2.8	1.6	0.6	0.3	1.5	0.9	0.0	4.5	3.3	0.7	0.5	8.4	4.5	53.1	0.1	0.6	2.4	0.1	0.1	0.1	0.2	0.0	0.0	3.1	0.3	0.1	0.0	0.0	3.9	0.2	0.4	0.4	0.0	0.3	0.1	0.0	0.0	0.3	0.2	35.3	0.2	5.3	1.0	0.6	8.9	0.2	0.0	0.1	0.1	0.0	18.3	1.6	0.0	0.1	0.9	15.2	0.1	0.1	2.6	1.5	6.7	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	1.0	0.3	0.1	0.0	0.3	0.0	0.5	0.9	0.1	0.3	8.5	0.2	4.5	2.6	2.6	0.2	9.7	0.5	0.5	0.3	0.2	8.4	0.4	0.3	0.1	0.7	0.1	53.1	2.7	0.6	2.4	0.4	0.4	0.2	2.0	0.5	0.3	0.4	0.0	2.4	0.3
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122213-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 123.9"	"Group enriched"	"Detected in some"	6	"EFO-21: 57.2;HDLM-2: 14.5;HHSteC: 21.2;hTCEpi: 19.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 7.6;T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		47000	47000	Vesicles	Vesicles	"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favourable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavourable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.5	0.7	0.4	14.1	0.4	0.0	0.5	0.3	0.4	1.0	0.6	0.1	0.6	0.4	0.4	1.0	2.5	0.5	0.8	0.4	0.4	0.4	0.8	0.6	123.9	11.2	0.4	0.1	0.4	8.3	0.0	0.6	1.0	0.6	1.0	1.7	0.2	6.8	1.9	0.4	1.9	1.4	0.8	0.5	2.0	0.8	8.4	0.0	21.3	8.3	3.1	11.3	3.3	0.9	0.4	0.0	7.6	0.1	0.8	6.6	1.1	3.4	0.1	0.0	0.5	0.0	0.0	2.8	0.0	0.9	0.6	0.1	0.8	1.8	0.0	57.2	0.2	0.5	1.2	2.1	0.1	14.5	1.7	0.0	0.1	0.1	21.2	0.0	0.5	0.3	19.4	0.0	2.5	2.6	0.1	3.4	0.1	0.0	0.8	0.1	0.1	0.8	0.0	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.1	1.5	1.1	0.1	2.7	0.0	1.0	0.1	0.0	1.2	4.3	0.1	0.0	0.0	0.0	0.4	0.1	7.6	0.4	0.0	3.2	0.1	2.7	1.7	0.0	0.4	3.5	2.0	1.9	0.8	0.1	0.0	6.6	1.1	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.6	0.0
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040778-6054049	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 9.5;kidney: 13.0;lung: 36.4"	"Cell line enriched"	"Detected in some"	13	"RPTEC TERT1: 39.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									32000	32000				"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	9.5	0.1	0.0	2.4	1.1	0.1	0.1	0.0	0.2	0.7	2.2	0.0	0.0	0.1	0.1	2.8	0.1	1.5	0.1	1.1	0.0	0.2	13.0	0.4	36.4	0.1	0.0	0.0	1.6	2.6	0.1	0.0	3.4	0.0	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	39.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.4	0.2	0.9	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937740-79982614	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lung: 127.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.5;MCF7: 3.4;U-2197: 2.6"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.4;non-classical monocyte: 21.6"	"Lineage enriched"	"Detected in many"	17	"monocytes: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	5500000	5500000			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	0.3	0.3	0.6	0.3	1.1	3.9	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.3	0.3	127.0	0.3	0.3	0.3	0.3	0.9	0.3	0.7	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	1.6	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	1.2	0.4	0.3	0.3	0.3	0.0	1.2	0.4	21.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.2	0.7	2.4	0.3	0.1	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	2.7	0.0	7.5	0.0	0.0	0.0	0.0	0.4	0.0	3.4	0.1	1.8	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.5	0.0	1.0	0.7	1.4	0.0	0.2	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	6.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.5	0.6	1.1	0.3	0.6	0.5	0.5	0.3	0.3	0.3	0.3
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RH-30: 2.6;SH-SY5Y: 3.6"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.2"	"HPA043322, HPA058399"	Enhanced									"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.5	0.5	0.0	0.0	0.0	0.3	0.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.4	2.6	0.2	0.2	0.4	0.3	3.6	0.1	0.4	0.0	0.1	0.3	0.0	0.7	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	930000	930000	"Golgi apparatus"	"Golgi apparatus"	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
AL132671.2		ENSG00000282218			6	117318211-117573571	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"epididymis: 3.7;lung: 2.6"	"Cell line enriched"	"Detected in single"	37	"U-138 MG: 14.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019477	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA019477: AB_1849890"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	3.7	0.0	0.0	0.0	0.0			0.0	0.0	2.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.7;THP-1: 27.4;U-266/70: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019816	Enhanced					2200000	2200000			"HPA019816: AB_1853923"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	4.9	2.8	2.8	28.3	3.8	35.2	4.3	0.9	2.2	2.1	4.8	3.8	0.6	4.4	2.1	2.6	3.2	3.3	5.4	2.7	3.0	2.2	4.6	3.5	17.5	42.2	5.4	1.2	1.2	1.5	0.5	2.5	5.8	3.9	3.2	1.7	3.2	6.7	1.5	1.2	2.0	23.4	2.0	4.9	50.4	6.1	1.7	4.6	45.0	4.3	1.8	38.4	4.3	4.3	9.3	9.4	15.7	9.2	11.3	32.1	21.0	3.2	0.6	0.0	3.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	8.7	4.2	21.9	0.9	0.0	2.9	0.6	0.1	0.0	16.0	0.3	2.9	6.0	1.0	0.1	14.2	17.3	0.0	0.9	0.0	0.0	0.0	1.9	30.7	0.0	0.2	15.8	12.7	2.3	1.6	15.3	0.1	21.7	0.0	0.0	0.1	0.0	5.0	0.0	1.3	1.0	27.4	1.4	0.0	0.6	0.0	0.0	40.4	17.3	17.5	0.1	21.4	1.6	2.7	9.2	9.8	20.4	9.0	17.8	7.3	23.2	24.2	9.4	9.3	32.1	23.3	15.7	11.3	8.4	5.6	18.2	21.0	2.8	3.8	0.9	2.2	3.0	2.2	5.4	1.2	3.9	4.6
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1"	"Group enriched"	"Detected in some"	6	"THP-1: 15.6;U-937: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 47.8"	"Group enriched"	"Detected in many"	46	"dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1"									HPA013712	Supported									"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	3.3	1.0	1.2	9.8	3.1	18.2	0.9	1.5	1.3	0.8	2.3	3.1	0.0	2.7	0.7	0.7	0.9	1.1	1.9	2.4	1.3	1.2	1.1	1.5	24.1	15.6	3.8	0.5	0.9	0.9	0.0	1.0	2.1	2.6	1.4	2.6	0.8	1.9	0.3	0.5	0.5	3.4	2.3	5.8	29.1	1.0	0.7	2.4	1.1	0.8	0.0	4.2	2.8	0.8	0.0	13.5	47.8	38.1	0.7	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	30.2	0.0	8.4	20.2	47.8	0.0	34.4	0.1	0.0	0.0	0.0	13.5	0.0	0.0	0.0	15.9	0.7	38.1	1.4	0.0	8.2	1.2	3.1	1.5	1.3	1.3	1.2	3.8	0.5	2.6	2.4
CLEC6A	"CLECSF10, dectin-2"	ENSG00000205846	"C-type lectin domain containing 6A"	Q6EIG7	12	8455926-8478330	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 8.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 8.4;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.5;monocytes: 8.4"	"Low region specificity"	"Detected in many"																		"unprognostic (1.44e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.27e-4)"		"unprognostic (6.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"		"unprognostic (7.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-2)"	0.2	0.2	0.1	4.9	0.2	0.5	0.2	0.1	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.8	0.2	0.3	0.2	2.3	0.5	0.2	0.4	0.8	6.2	5.0	0.2	0.0	0.1	0.3	0.0	0.2	0.9	0.4	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.4	0.9	0.1	0.5	0.0	0.7	0.2	0.0	1.7	1.1	0.2	0.0	3.5	0.5	8.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.2	0.1	0.1	0.5	0.2	0.2	0.0	0.4	0.0
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"lung: 9.6;skin 1: 11.1"	"Cell line enriched"	"Detected in single"	63	"HDLM-2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"					"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.2	0.0	0.2	0.2	0.5	0.1	1.0	0.2	0.2	0.2	0.4	0.2	0.2	1.5	0.2	0.2	2.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	9.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	11.1	1.8	0.2	0.2	0.2	1.5	1.1	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adipose tissue: 28.8;lung: 18.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.1;RPMI-8226: 1.2;U-87 MG: 4.4;U-937: 1.6"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enriched"	"Detected in single"	4	"amygdala: 3.5"	"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	28.8	0.1	3.5	0.3	0.2	0.4	1.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.3	0.0	0.8	0.2	0.1	1.0	18.2	0.8	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.4	1.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	3.5	0.2	0.0	0.6	0.8	0.2	0.2	0.0	0.2	0.0
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.7;MCF7: 2.2;U-2197: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	33000000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	0.0	0.4	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2
IL7R	CD127	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1"	"Cell line enhanced"	"Detected in many"		"BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1"	"Group enriched"	"Detected in many"	33	"NK-cells: 19.1;T-cells: 70.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB010215			Supported	"Plasma membrane,Centriolar satellite"	"Intracellular and membrane"	180000	180000	"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"CAB010215: AB_673727"	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	6.7	3.6	0.7	34.0	0.7	3.1	4.8	0.5	0.6	4.8	20.6	0.3	0.9	3.5	1.8	2.9	6.6	3.7	8.5	1.9	0.7	0.7	7.0	2.7	52.6	133.1	0.8	0.1	2.5	1.7	0.0	1.5	1.2	0.8	3.3	5.4	1.7	13.2	1.8	0.9	1.8	34.0	1.2	1.5	32.3	7.8	3.0	0.4	130.9	5.1	5.3	42.9	12.6	4.6	0.4	0.3	1.3	0.2	19.1	70.3	12.7	0.1	0.0	0.1	0.1	0.1	0.1	0.2	21.7	11.0	19.6	11.6	0.1	0.1	2.1	0.0	40.7	3.5	0.0	1.3	37.4	1.8	0.2	0.6	2.3	0.0	0.3	0.1	1.5	0.3	0.0	4.2	0.9	0.5	0.1	0.3	15.4	0.0	0.5	0.2	0.1	1.0	84.6	1.1	0.1	0.0	1.2	0.0	0.0	3.6	0.3	0.0	0.1	0.0	1.5	7.7	13.1	3.3	2.8	0.1	0.0	2.4	3.9	2.0	5.9	0.5	0.2	0.1	19.2	0.2	70.3	0.2	39.9	28.0	0.1	0.4	34.5	22.5	1.3	19.1	0.2	0.3	6.7	12.7	0.7	0.7	0.5	0.6	0.7	0.7	0.8	0.1	0.8	0.4
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 88.1;lung: 70.4"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.1;REH: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 16.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					25000	25000			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	88.1	9.0	2.2	6.1	4.5	3.7	6.9	10.4	3.3	4.5	3.1	1.8	1.0	2.1	3.1	6.2	2.4	4.5	11.4	8.0	3.8	3.1	9.5	13.6	70.4	6.9	4.3	0.8	6.7	3.8	1.2	2.6	10.4	7.7	3.2	3.9	4.5	6.2	2.3	3.2	1.6	4.0	6.5	11.9	10.9	2.5	4.9	3.1	1.5	2.2	1.7	0.7	10.8	1.8	1.5	1.0	3.0	16.0	0.3	1.3	0.5	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.3	47.1	0.1	0.2	1.6	0.1	1.5	2.4	0.4	0.3	0.3	0.4	0.9	0.2	1.9	1.9	1.8	1.8	0.4	1.0	1.1	0.3	0.3	0.3	0.7	0.0	0.7	1.4	0.9	1.8	0.6	0.6	0.2	0.6	17.8	1.0	0.4	0.9	2.7	1.0	0.5	0.4	1.2	0.1	0.1	0.5	1.1	1.2	0.5	4.9	1.2	4.8	3.7	3.2	0.5	0.6	1.0	1.1	3.1	0.5	0.9	16.0	0.4	0.9	0.7	0.7	1.0	1.5	1.3	0.9	3.0	0.3	7.8	0.5	0.6	0.5	2.2	4.5	10.4	2.7	3.8	3.1	4.3	0.8	7.7	3.1
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.2;HL-60: 15.0;HMC-1: 26.5;NB-4: 59.1;THP-1: 44.0;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055242	Enhanced					8800	8800			"HPA055242: AB_2682754"	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	15.2	0.0	10.9	0.0	0.0	0.0	15.0	26.5	0.1	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	59.1	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	44.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	24.3	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959947-79090773	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.3;lung: 13.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.7;BEWO: 7.5;Karpas-707: 10.0;RPMI-8226: 12.0;U-2 OS: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	1.0	1.1	7.6	2.3	12.2	0.8	1.1	34.3	33.0	1.9	1.1	11.5	0.0	1.1	1.6	1.1	1.0	1.5	1.0	0.9	12.8	8.6	1.3	0.9	13.0	2.8	8.9	12.0	2.3	4.5	0.9	0.8	1.2	19.2	1.7	1.2	0.4	0.9	1.2	0.8	0.9	1.2	1.0	16.9	1.8	1.1	1.2	5.8	0.0	0.8	0.0	3.1	1.7	0.3	1.9	0.2	0.0	0.0	0.0	0.6	0.1	7.7	0.1	0.1	0.0	0.0	0.0	7.5	0.0	0.4	0.4	1.1	0.0	1.4	0.4	0.2	0.0	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.0	10.0	1.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	12.0	0.0	0.3	0.8	0.0	0.0	0.1	1.5	0.0	1.6	0.0	0.0	14.7	0.0	0.2	0.0	3.4	2.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.6	12.2	34.3	33.0	12.8	8.6	8.9	12.0	19.2	5.8
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 6.2;T-47d: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8000000	8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;Hep G2: 2.1;THP-1: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.1	0.0	0.0	5.3	0.5	0.4	0.4	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.1	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.0	10.5	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell line enriched"	"Detected in some"	8	"Daudi: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"					"Low region specificity"	"Detected in single"									270000	270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Group enriched"	"Detected in some"	5	"EFO-21: 6.4;HeLa: 1.6;TIME: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046432	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA046432: AB_2679664"	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC78	"C16orf25, FLJ34512"	ENSG00000162004	"Coiled-coil domain containing 78"	A2IDD5	16	722582-726954	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.6;RPMI-8226: 10.1;SCLC-21H: 12.1;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.10e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.82e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-3)"	0.3	1.1	3.6	1.1	11.3	1.2	0.5	2.0	1.2	2.5	0.4	6.4	1.3	0.3	1.1	21.3	0.3	47.9	0.6	0.4	4.3	4.7	0.4	0.4	13.3	1.1	1.9	0.1	5.7	0.3	0.7	2.3	0.6	20.1	0.6	0.5	0.3	0.7	1.0	0.4	0.4	0.6	0.4	2.6	0.9	0.9	1.1	1.7	0.2	0.5	0.1	1.6	1.0	0.1	0.4	1.2	1.3	0.0	1.2	3.2	0.1	0.5	1.0	1.2	2.8	1.3	1.1	1.3	1.0	2.4	0.6	0.4	0.4	4.7	1.0	1.0	0.6	0.8	2.7	1.5	0.1	8.6	0.0	2.4	1.4	0.0	1.5	0.8	1.5	3.7	0.8	0.3	4.3	0.4	0.3	3.3	0.8	6.0	0.0	2.0	1.8	0.3	2.1	0.9	10.1	4.1	1.8	12.1	1.2	1.1	7.1	0.6	4.6	1.6	1.0	0.9	0.4	0.0	0.1	10.0	0.2	2.6	0.9	1.1	2.8	0.0	0.0	1.3	0.2	0.0	3.2	0.4	0.1	1.9	0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.2	0.1	0.1	3.6	11.3	2.0	1.2	4.3	4.7	1.9	0.1	20.1	1.7
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.1;U-266/70: 11.2;U-266/84: 5.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdTCR: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"									CAB007805	Approved				"Secreted to blood"					"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.54e-4)"	"prognostic favourable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	5.4	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6										
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8"	"Group enriched"	"Detected in some"	16	"Karpas-707: 59.3;U-266/84: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 53.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"														"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	7.1	5.0	6.3	27.7	7.4	43.9	3.7	0.9	3.4	3.9	4.5	9.5	0.5	3.7	3.2	8.9	8.7	5.3	7.4	5.2	6.2	4.2	8.7	6.9	32.8	24.2	8.9	4.3	2.4	2.8	1.6	2.6	7.8	8.6	2.7	5.0	6.4	6.5	2.4	1.2	3.2	6.5	5.7	18.7	28.8	3.1	1.6	7.3	5.1	2.3	3.2	9.1	5.5	3.8	0.1	13.1	53.9	30.1	0.1	0.1	7.4	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.3	46.2	0.0	0.1	0.3	0.0	0.2	26.4	0.4	0.0	29.5	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	53.9	0.1	30.1	0.2	0.0	7.4	6.3	7.4	0.9	3.4	6.2	4.2	8.9	4.3	8.6	7.3
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain									"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.4	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.5	2.7	0.2	0.0	0.1	0.9	0.4	1.3	0.9	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.6	0.5	0.3	0.2	0.0	0.6	2.8	0.6	0.2	0.7	0.4	0.3	1.1	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.7	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"intestine: 15.8;lung: 11.7;pituitary gland: 39.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 2.7;HaCaT: 5.5;NB-4: 6.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042563			Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	5.2	0.6	1.8	2.8	1.7	0.2	1.9	0.1	2.6	0.2	11.3	1.1	0.0	0.7	0.1	0.1	0.4	1.4	2.6	1.2	0.9	1.6	0.3	0.6	11.7	1.3	0.6	1.0	0.3	1.1	0.1	39.2	0.4	0.8	0.2	15.8	0.3	0.9	0.1	0.5	1.3	1.0	0.3	2.6	0.2	0.7	2.0	0.9	0.7	0.2	0.0	0.6	0.3	0.2	0.5	3.4	1.3	3.0	0.7	0.3	0.8	0.1	3.3	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.7	0.8	0.2	0.5	0.0	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.9	3.0	0.2	0.3	0.6	0.2	0.4	0.2	0.2	3.4	0.5	0.2	0.3	1.3	0.7	0.4	0.4	0.1	0.8	1.8	1.7	0.1	2.6	0.9	1.6	0.6	1.0	0.8	0.9
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814177-22916338	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 12.7;brain: 38.2;lung: 13.4"	"Group enriched"	"Detected in some"	5	"HaCaT: 10.2;SH-SY5Y: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017736	Approved									"HPA017736: AB_1851095"	"unprognostic (4.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (5.97e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"prognostic favourable (1.35e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.00e-2)"	12.7	1.7	3.8	1.1	6.5	1.1	2.4	0.5	38.2	2.0	1.4	0.3	0.3	1.0	1.0	1.0	1.2	1.0	1.1	3.8	7.8	4.3	1.0	2.2	13.4	2.1	2.2	8.4	4.5	1.0	1.0	0.4	1.2	1.5	2.0	1.4	5.0	2.9	1.1	1.0	2.0	1.0	1.2	1.0	1.1	1.1	1.1	0.0	0.0	1.8	0.4	1.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.5	0.5	19.1	7.8	4.3	2.2	8.4	1.5	0.0
HTR3C		ENSG00000178084	"5-hydroxytryptamine receptor 3C"	Q8WXA8	3	184053047-184060671	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"lung: 6.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.1;HEL: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"																	"unprognostic (4.56e-2)"		"unprognostic (2.01e-1)"		"unprognostic (1.39e-1)"		"unprognostic (1.61e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.72e-2)"	"unprognostic (1.75e-1)"		"unprognostic (3.88e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3			1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.2		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.2	0.0	0.6	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	1700000	1700000	"Plasma membrane"	"Plasma membrane"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol	Cytosol	"HPA024826: "	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 40.4;lung: 50.4"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7"	"Group enriched"	"Detected in many"	7	"lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 40.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 40.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	3.7	3.4	2.3	7.0	3.9	8.6	3.0	1.7	5.0	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4.0	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1.0	1.9	3.6	1.6	3.3	4.2	2.0	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0.0	0.0	0.8	0.0	9.7	0.1	0.0	3.9	10.0	0.1	2.1	5.6	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.4	0.0	0.7	0.3	0.2	0.0	0.7	0.5	0.1	2.5	0.7	0.0	0.2	0.6	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.6	0.0	0.2	2.7	2.8	2.2	1.4	1.1	1.1	1.2	0.7	0.0	0.0	0.0	2.3	0.0	0.5	0.0	5.8	1.2	0.0	3.1	0.0	0.9	0.0	0.0	1.5	0.9	0.0	0.0	40.4	0.0	3.0	0.2	0.0	0.8	2.3	3.9	1.7	5.0	1.8	1.4	2.2	3.6	1.9	2.4
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Cytosol	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.5;THP-1: 6.6;U-87 MG: 7.2;U-937: 6.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	72000000	72000000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.1	0.7	0.0	0.0	0.2	0.6	4.7	0.0	0.0	0.4	0.1	0.1	0.0	5.3	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.8	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.5	16.5	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"	"Golgi apparatus, Vesicles, Plasma membrane"	"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.4	2.7	3.3	4.2	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.3	1.1	0.9	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	4.9	4.9	1.9	1.6	1.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	2.5	4.8	2.7	2.4	0.5	1.3	0.3	1.5	3.9	3.3	3.0	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268707	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lung: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 24.9;HaCaT: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"T-reg: 15.4"	"Lineage enriched"	"Detected in single"	47	"T-cells: 15.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0.0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3.0	0.3	0.2	0.3	0.1	0.2	15.4	0.2	24.9	1.4	13.4	6.2	0.0	0.1	3.3	3.6	4.2	4.1	6.5	10.4	5.0	0.0	1.6	1.4	20.0	7.5	0.6	4.3	3.5	5.1	4.1	3.0	4.3	0.0	5.5	3.2	0.2	0.3	5.1	0.5	0.6	0.2	0.2	5.5	3.1	10.8	7.2	5.6	5.1	9.3	14.3	0.0	2.6	10.9	7.3	8.4	2.4	8.4	3.4	7.6	3.1	0.0	1.9	12.2	0.1	9.1	0.1	0.0	9.5	2.4	0.0	2.9	0.1	0.1	0.1	1.3	0.0	0.1	0.1	2.1	0.4	0.0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Group enriched"	"Detected in some"	9	"HEK 293: 2.7;U-2 OS: 9.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA066281: AB_2685647"	"unprognostic (9.84e-3)"	"prognostic favourable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Group enriched"	"Detected in some"	5	"AF22: 111.0;ASC diff: 33.0;Hep G2: 89.4;SK-MEL-30: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	220000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	111.0	0.0	33.0	2.4	0.3	13.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	89.4	0.0	0.1	0.1	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	Vesicles	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.5	1.8	14.8	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.1	0.2	8.5	0.1	0.3	14.9	5.7	0.9	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	14.4	10.2	0.0	0.0	12.7	0.0	1.0	2.0	4.6	2.3	0.3	1.6	8.5	0.3	20.8	14.9	1.8	10.5	0.2	34.2	0.9	4.1	0.1	0.5	4.0	4.2	2.8	1.2	0.0	2.1	5.1	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1
AC009086.2		ENSG00000277669			16	29663279-29695144	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 17.3;lymphoid tissue: 55.9"	"Group enriched"	"Detected in some"	5	"BEWO: 18.9;EFO-21: 50.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 4.0;intermediate monocyte: 4.5;myeloid DC: 5.3;non-classical monocyte: 7.2;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.3;monocytes: 7.2"									HPA011887	Uncertain									"HPA011887: AB_2668555"																		3.4	0.4	0.3	8.5	1.3	1.9	0.4	0.0	0.5	0.4	9.5	1.2	0.0	6.8	0.4	0.4	0.7	0.4	1.4	2.2	0.1		0.4	0.5	17.3	12.5	2.0	0.0	0.4	0.5	0.4	0.0	0.4	1.0	0.4	0.4	0.5	3.1	0.4	0.4	0.4	2.5	0.4	2.7	8.3	1.5	0.4	0.7	55.9	0.4	0.6	11.7	0.4	0.0	0.0	5.3	0.0	7.2	0.1	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	3.6	0.0	0.0	2.0	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.7	0.0	0.3	0.0	0.0	4.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.1	7.2	2.8	0.7	1.5										
AC078864.2		ENSG00000284791			12	52079696-52108239	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lung: 23.3;prostate: 18.7;testis: 15.3"	"Group enriched"	"Detected in some"	5	"HHSteC: 2.4;MOLT-4: 1.6;RPMI-8226: 1.8"									"Cell type enriched"	"Detected in single"	87	"plasmacytoid DC: 8.7"	"Lineage enriched"	"Detected in single"	87	"dendritic cells: 8.7"					"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	1.2	1.1	1.9	0.0	0.0	0.8	0.2	0.1	3.0	0.0	1.4	2.2	0.0		0.0	0.1	23.3	0.6	0.9	0.0	4.1	0.3	0.0	0.0	0.8	0.0	18.7	1.4	0.0	0.0	0.6	0.1	0.0	1.4	4.3	0.6	9.1	1.1	15.3	0.0	0.0	0.0	0.2	2.5	4.8	1.5	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0										
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187939-210225491	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 29.5;thyroid gland: 29.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.1;HEK 293: 2.4;HeLa: 7.3;RPTEC TERT1: 6.6;RT4: 2.5;U-2 OS: 3.7"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported								"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	9.6	1.1	2.0	1.0	1.8	0.0	10.7	1.4	1.8	3.2	0.8	1.5	4.5	0.1	0.7	6.8	1.3	2.3	2.1	2.2	2.4	1.0	17.3	23.0	29.5	0.0	1.6	2.3	12.2	19.3	11.6	5.8	1.2	3.4	14.5	0.2	3.2	9.9	4.8	7.0	2.2	0.3	1.5	3.1	0.0	3.3	4.2	0.9	0.7	29.7	3.7	0.0	0.7	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.6	0.0	0.0	0.0	6.6	2.5	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	1.4	1.8	2.4	1.0	1.6	2.3	3.4	0.9
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;RPMI-8226: 13.6;SK-MEL-30: 40.4;U-138 MG: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002584, HPA057655, HPA059463"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	3700000	3700000	Cytosol	Cytosol	"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: "	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.2	0.4	0.0	0.0	0.2	0.0	14.3	0.4	9.6	0.0	0.0	0.0	0.1	0.4	0.6	2.8	0.1	0.0	1.4	0.0	3.6	0.3	0.1	0.0	1.7	0.5	0.0	0.2	0.0	1.1	0.1	0.0	0.0	10.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.1	0.7	13.6	0.0	0.1	0.2	0.3	0.0	0.0	40.4	0.0	0.1	0.3	38.0	0.4	0.7	0.1	0.2	1.8	0.2	7.8	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.1;ASC TERT1: 12.4;EFO-21: 16.0;HUVEC TERT2: 58.5;TIME: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 3.6;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 5.0;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"					"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	25.5	5.1	3.2	9.3	4.3	0.2	15.6	1.6	3.6	15.1	20.1	3.7	13.1	4.9	12.7	11.0	12.1	13.9	11.0	15.4	3.7	3.2	13.6	3.4	55.0	19.1	4.9	3.6	5.9	6.1	21.6	2.7	44.1	5.3	12.3	14.7	12.3	6.9	10.6	14.2	8.0	11.1	8.2	3.7	14.8	8.1	3.5	3.6	1.7	12.9	6.8	5.4	9.3	11.2	0.1	5.0	0.3	3.6	0.0	0.1	0.7	0.0	0.2	0.1	0.0	18.1	12.4	0.0	0.8	1.6	0.0	0.0	0.1	0.1	0.0	16.0	6.8	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	2.7	0.0	0.4	5.0	0.0	0.1	0.0	58.5	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	45.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.7	3.2	4.3	1.6	3.6	3.7	3.2	4.9	3.6	5.3	3.6
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404925-130428993	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 13.0;lung: 21.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.9;HMC-1: 5.7;NTERA-2: 2.8;U-2 OS: 12.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2"	HPA066349	Approved				"Secreted to extracellular matrix"	2200000	2200000			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	2.1	0.1	1.5	10.2	2.5	0.0	0.5	0.6	4.4	1.3	5.3	0.5	0.2	1.1	2.6	1.5	3.1	1.7	13.0	3.9	1.6	0.6	2.1	0.2	21.0	0.2	0.7	0.2	1.0	0.7	0.0	0.8	2.7	0.9	2.9	0.5	0.7	0.3	5.7	0.4	0.1	1.6	7.4	0.8	0.9	5.6	0.2	0.4	0.2	0.4	0.2	0.4	3.8	3.4	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.5	0.6	3.2	1.6	0.6	0.7	0.2	0.9	0.4
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852512-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 54.6"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 13.1;TIME: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"													23000000	23000000				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favourable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	32.6	11.9	5.0	3.4	7.1	0.2	27.5	2.1	5.8	6.6	5.3	4.2	7.0	2.9	10.4	8.9	5.9	6.7	8.5	34.3	6.4	4.9	33.6	8.7	54.6	6.1	7.3	4.7	6.5	3.3	7.0	5.2	25.1	5.9	5.5	3.1	7.5	3.5	5.0	19.4	3.8	4.0	11.1	6.1	26.2	3.8	3.1	3.0	0.1	16.1	8.8	1.7	8.1	13.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	7.1	2.1	5.8	6.4	4.9	7.3	4.7	5.9	3.0
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170722-116174972	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6"	"Cell line enriched"	"Detected in single"	6	"HSkMC: 1.3"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 3.8"															"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.3	1.6	0.1	0.8	0.1	0.0	0.1	1.0	0.1	5.3	0.4	0.1	0.1	0.0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0.0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AL645941.2		ENSG00000248993			6	32937364-32953122	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lung: 18.7;lymphoid tissue: 19.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;SK-MEL-30: 1.4;U-698: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.3;intermediate monocyte: 1.5;memory B-cell: 2.6;myeloid DC: 1.7;naive B-cell: 1.0;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;dendritic cells: 1.7;monocytes: 1.5"									HPA012298	Uncertain									"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"		10.0	2.9	1.7	12.1	2.8	2.3	2.4	1.6	2.0	3.0	5.6	3.7	1.7	4.0	2.8	5.5	1.8	1.7	4.3	5.3	1.8	1.8	8.3	1.7	18.7	10.8	3.8	0.0	2.4	5.0	1.7	2.1	1.9	3.6	2.6	2.0	3.0	7.3	3.8	2.8	2.0	12.7	1.9	5.5	13.2	3.5	1.8	2.7	7.3	7.1	4.7	19.3	2.1	1.9	2.6	1.7	0.2	1.5	0.0	0.2	0.6	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.1	0.4	0.0	0.2	0.6	0.0	0.0	0.5	0.4	1.3	0.2	0.2	0.2	0.0	1.3	0.2	0.0	1.5	0.0	2.6	0.0	0.1	1.7	1.0	0.0	0.0	0.1	0.0	0.2	1.1	0.2	0.6	1.7	2.8	1.6	1.6	1.8	1.8	3.8	0.0	3.6	2.7
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.1;MCF7: 14.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved									"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.3	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	7300000	7300000	Cytosol	Cytosol	"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 24.5;HaCaT: 18.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB020698, HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB020698: , HPA038764: AB_2676194, HPA038765: , HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	24.5	0.0	0.0	0.0	18.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A3		ENSG00000276203	"Ankyrin repeat domain 20 family member A3"	Q5VUR7	9	66106815-66153135	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;lung: 1.3;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HDLM-2: 5.1;RPTEC TERT1: 1.4;WM-115: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain									"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.27e-2)"													0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	1.1	0.1	0.0	0.0			0.0	0.0	1.3	0.1			0.0	0.0	0.0		0.0		0.0	0.5		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	2.0			0.2		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.1	0.0	5.1	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"					"Low region specificity"	"Detected in many"			HPA053749	Uncertain									"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.6	0.8	0.8	0.3	0.0	0.1	0.6	0.3	0.0	0.1	0.0	1.2	1.2	1.1	0.2	0.0	1.8	0.5	0.6	0.2	0.6	0.4	1.1	2.5	0.5	0.0	0.5	0.9	0.2	0.0	0.0	0.1	0.0	0.6	1.0	0.0	0.4	0.7	1.1	0.5	0.6	1.1	0.8	0.7	0.0	1.1	0.7	0.1	0.5	0.6	0.0	1.0	0.3	0.0	0.7	0.6	0.3	0.4	0.7	0.5	1.0	0.5	1.0	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732186	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;lung: 37.1;parathyroid gland: 27.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 26.9;U-2 OS: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in brain"						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	5.4	4.0	13.8	1.3	14.0	0.6	3.6	1.3	18.0	4.5	1.0	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6.0	0.9	0.8	27.7	1.0	1.4	19.3	4.1	1.3	6.0	2.8	4.5	10.9	3.0	0.9	1.1	25.5	1.1	1.1	5.0	8.5	1.3	8.5	1.0	1.2	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	3.0	0.1	4.0	0.4	4.4	0.0	0.0	0.0	1.1	0.1	2.2	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	26.9	0.0	0.0	0.0	0.0	1.5	0.5	1.5	0.0	1.3	0.4	0.0	0.0	0.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.0	1.3	7.6	11.1	7.9	5.7	6.0	19.3	8.5
BCL2A1	"ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1"	ENSG00000140379	"BCL2 related protein A1"	Q16548	15	79960889-79971446	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;bone marrow: 105.7;lung: 45.6"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 94.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 37.1;intermediate monocyte: 25.3;neutrophil: 72.7;non-classical monocyte: 47.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 72.7;monocytes: 47.2"																				"unprognostic (3.19e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.54e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	21.6	0.9	1.9	22.6	4.0	105.7	1.8	0.5	1.8	1.0	2.0	0.4	0.0	1.0	0.7	1.0	3.0	4.9	3.6	9.8	2.2	1.3	1.8	5.2	45.6	24.9	11.8	0.0	3.7	1.0	0.2	2.2	3.8	3.8	1.6	1.3	0.8	2.3	0.3	1.4	0.6	4.4	2.7	8.2	32.8	1.9	4.6	4.0	4.3	2.3	1.4	11.1	4.8	7.1	9.3	3.4	72.7	47.2	2.8	5.7	5.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.7	0.2	0.0	0.0	0.0	0.2	0.4	0.5	20.1	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	94.5	0.0	0.9	0.0	10.3	0.8	0.0	0.1	0.1	0.0	0.7	0.4	6.4	4.8	3.3	5.6	37.1	3.6	25.3	2.0	9.3	4.7	4.7	3.4	5.9	5.7	5.3	72.7	2.8	47.2	0.6	1.0	5.8	1.9	4.0	0.5	1.8	2.2	1.3	11.8	0.0	3.8	4.0
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 15.7;RT4: 13.1;SK-BR-3: 5.9"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 2.0;RT4: 4.1;SK-BR-3: 8.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Low region specificity"	"Detected in all"			HPA024256	Enhanced				"Secreted in other tissues"	7500000	7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.7	0.0	0.3	0.0	4.1	0.0	0.0	0.0	8.4	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1
C12orf74		ENSG00000214215	"Chromosome 12 open reading frame 74"	Q32Q52	12	92702843-92708549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;RT4: 2.4;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"memory B-cell: 3.7;naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	21	"B-cells: 3.7"																				"unprognostic (2.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.28e-3)"	"unprognostic (4.55e-3)"		"unprognostic (7.95e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.83e-4)"	"unprognostic (3.03e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.42e-2)"	0.2	0.1	0.1	12.3	0.1	0.0	0.2	0.1	0.1	2.1	0.7	0.0	3.6	0.3	0.7	6.9	1.7	4.5	0.3	0.2	0.1	0.1	1.3	0.5	6.6	1.9	0.1	0.0	1.0	1.1	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.9	0.9	0.1	0.2	1.8	0.0	0.1	2.6	2.1	0.5	0.0	0.1	0.2	0.0	10.5	2.5	1.4	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	2.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.8;thyroid gland: 79.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.8;Hep G2: 5.8;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 4.9"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	1200000	1200000			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	6.0	1.7	7.7	4.4	9.3	0.3	4.7	5.1	8.6	7.3	2.3	5.2	0.3	5.9	1.4	30.3	2.5	4.6	15.3	7.1	6.1	3.0	5.6	0.3	35.8	0.5	6.2	7.4	1.9	8.2	0.3	1.9	0.5	5.3	4.0	1.9	5.0	11.5	0.6	0.2	0.4	2.8	6.2	7.4	0.4	28.0	1.4	2.9	0.0	79.3	2.7	1.4	4.3	1.8	1.1	0.9	3.3	0.5	1.3	0.6	0.2	0.1	0.2	0.0	0.4	4.8	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.6	1.4	5.8	3.1	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.6	0.7	3.6	0.1	0.5	0.1	0.3	0.0	0.5	0.6	0.4	0.3	0.6	1.1	0.4	0.0	0.2	0.6	0.3	4.9	0.2	0.4	0.2	0.1	0.4	0.2	0.1	3.3	0.5	0.7	0.4	0.4	0.3	0.7	0.4	0.4	0.2	1.1	0.5	0.6	1.9	1.3	0.2	0.9	0.3	0.2	7.7	9.3	5.1	8.6	6.1	3.0	6.2	7.4	5.3	2.9
C19orf85		ENSG00000283567	"Chromosome 19 open reading frame 85"		19	55463002-55464707	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lung: 1.7;seminal vesicle: 1.3;testis: 1.1"	"Cell line enriched"	"Detected in single"	83	"NTERA-2: 15.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		7900	7900	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	17.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	2.1	0.0	39.2	0.0	37.7	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.0	0.0	11.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	4.7	0.0	0.1	0.3	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2
C2orf91		ENSG00000205086	"Chromosome 2 open reading frame 91"	Q6ZV80	2	41935368-41954266	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;lung: 4.7"	"Group enriched"	"Detected in some"	6	"AN3-CA: 5.1;HDLM-2: 17.5"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.8"	"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042517	Uncertain									"HPA042517: AB_10795508"	"unprognostic (9.49e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	0.3	2.1	0.3	0.3	1.3	1.5	0.3	0.3	0.8	0.4	0.3	0.8	0.2	0.0	0.4	1.0	0.3	0.3	0.3	0.5	0.3	0.4	0.9	0.3	4.7	0.9	5.1	0.2	0.4	0.4	0.4	0.5	0.2	1.9	0.8	0.2	0.8	3.5	0.2	0.2	1.3	0.3	0.2	2.2	0.6	1.3	1.1	0.2	0.2	0.2	0.2	0.6	0.2	0.3	1.2	1.4	2.8	1.2	1.2	0.9	0.3	0.2	0.4	0.7	5.1	0.2	0.1	0.3	0.1	0.1	0.0	0.3	0.4	0.3	0.3	0.3	0.2	0.2	0.0	0.1	0.1	17.5	0.3	0.2	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.1	1.8	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.6	0.1	0.1	0.3	0.2	1.8	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.2	0.2	0.0	0.2	1.3	1.2	1.4	0.6	0.9	0.5	0.6	0.7	0.5	1.4	1.2	0.7	0.9	2.8	1.2	1.0	1.3	0.4	0.3	0.3	1.3	0.3	0.8	0.3	0.4	5.1	0.2	1.9	0.2
C6orf223	MGC45491	ENSG00000181577	"Chromosome 6 open reading frame 223"	Q8N319	6	44000580-44005958	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 23.6;lung: 9.4"	"Cell line enhanced"	"Detected in some"		"A-431: 16.8;RPTEC TERT1: 23.8;THP-1: 9.9;U-937: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA035765, HPA046117"	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA035765: AB_2797225, HPA046117: AB_10964082"	"unprognostic (2.94e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.34e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (9.38e-5)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.31e-1)"	0.1	0.4	1.1	1.3	0.9	0.5	23.6	0.2	3.0	0.7	1.4	0.0	0.0	1.8	0.8	4.7	0.1	0.2	6.9	2.9	1.1	0.8	4.9	1.4	9.4	2.8	0.1	1.2	0.1	2.4	0.1	0.8	0.2	0.9	0.2	0.7	3.4	3.1	0.1	0.3	0.5	3.1	0.2	0.0	0.7	0.2	0.3	0.0	1.0	2.1	1.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	9.9	0.0	0.0	0.2	0.3	0.0	0.1	2.0	3.5	1.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.2	3.0	1.1	0.8	0.1	1.2	0.9	0.0
C7orf77		ENSG00000275356	"Chromosome 7 open reading frame 77"	A4D0Y5	7	124777292-124790689	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"liver: 2.1;lung: 2.4"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (9.32e-2)"		"unprognostic (1.05e-1)"											0.0	0.0		0.0		0.0	0.6		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	2.1	2.4	0.0			0.1	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.8	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187343129-187448460	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.0"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.2;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	42.4	5.2	4.9	6.4	3.8	0.2	19.6	7.3	9.4	21.2	12.6	2.6	4.0	3.1	17.9	6.8	16.3	6.5	13.4	15.1	4.5	3.8	16.5	12.5	91.0	16.9	4.7	3.5	15.2	3.7	8.2	5.3	6.4	7.5	10.7	5.3	7.5	8.4	4.4	5.0	4.2	5.6	14.5	18.1	9.1	5.0	7.9	2.8	2.3	16.9	11.8	4.7	10.6	14.0	0.2	11.2	0.1	3.3	1.2	1.1	1.1	0.0	0.0	3.1	0.0	2.3	0.5	0.0	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.1	0.7	61.0	0.0	0.8	0.4	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.1	14.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.2	0.0	0.0	0.1	2.2	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	11.2	0.0	1.1	0.2	0.1	1.2	1.2	3.3	0.0	1.1	4.9	3.8	7.3	3.7	4.5	3.8	4.7	3.5	7.5	2.8
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.6;lung: 19.8;stomach 1: 35.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 18.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483"	Enhanced									"CAB033483: AB_1119945, HPA020398: AB_2670429"	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.2	0.7	0.4	7.0	0.3	0.0	0.2	0.3	0.5	0.4	10.4	0.4	0.2	3.9	0.2	0.2	0.7	1.5	12.7	0.2	0.5	0.2	0.2	0.2	19.8	0.2	0.6	0.2	0.3	0.2	0.0	0.6	0.2	0.2	0.8	13.7	0.2	8.1	0.2	1.3	0.0	17.6	0.2	1.1	0.2	35.8	0.2	0.2	0.2	0.2	1.0	7.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.1	18.3	0.0	0.0	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.4	0.5	0.2	0.6	0.2	0.2	0.2
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffolding protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.8;lung: 16.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.4;HEL: 10.5;HMC-1: 32.0;K-562: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 10.8;neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB034217	Approved					890000	890000			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	3.3	1.7	2.0	13.0	2.2	2.4	1.7	1.3	4.5	1.7	1.4	6.1	0.0	1.8	2.5	0.9	1.4	1.6	3.5	1.6	2.4	1.5	1.6	2.2	16.7	12.1	1.9	3.1	2.4	1.5	0.4	1.3	6.6	3.4	1.4	1.3	2.7	1.8	2.5	1.3	1.5	2.9	1.8	2.9	9.2	1.5	1.1	2.2	4.1	1.3	1.1	4.3	3.0	1.4	0.0	3.4	33.8	1.9	1.4	2.3	1.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.6	0.2	0.1	0.3	0.1	2.2	0.1	0.1	6.4	0.1	0.1	0.0	0.4	0.1	0.1	10.5	0.1	0.6	0.2	0.3	32.0	0.7	0.2	0.1	0.0	0.0	12.9	0.1	0.3	0.1	0.2	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.2	1.9	10.8	0.7	0.4	1.0	0.0	1.2	1.3	3.4	0.0	2.3	2.0	33.8	1.4	0.0	1.2	0.6	1.1	2.0	2.2	1.3	4.5	2.4	1.5	1.9	3.1	3.4	2.2
CCDC141	"CAMDI, FLJ39502"	ENSG00000163492	"Coiled-coil domain containing 141"		2	178829757-179050086	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 47.5;lung: 17.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;Daudi: 4.1;HEL: 9.3;RH-30: 5.0;U-266/70: 6.0;U-698: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 12.9"	"Group enriched"	"Detected in many"	9	"B-cells: 7.6;T-cells: 12.9"									HPA012718			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012718: "	"unprognostic (1.58e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (8.62e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.03e-3)"	"unprognostic (7.71e-8)"	"unprognostic (2.50e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-1)"	1.6	0.6	0.5	7.5	0.6	0.9	4.9	0.5	0.5	0.7	1.2	0.1	0.5	0.2	0.8	2.2	2.5	0.6	6.3	47.5	0.6	0.6	0.5	0.5	17.6	4.4	0.6	0.0	0.8	3.8	0.2	0.5	0.8	1.1	1.0	0.3	1.8	0.6	0.3	9.3	0.5	0.7	1.7	0.7	1.8	0.6	1.6	0.0	11.0	0.7	2.1	7.4	1.4	1.2	7.6	0.0	0.4	0.0	1.1	12.9	0.4	0.2	0.0	0.1	0.3	0.0	0.1	1.9	0.0	0.1	0.0	0.2	6.2	0.5	4.1	0.1	0.0	0.2	0.1	0.0	0.0	3.4	0.2	9.3	0.3	0.0	0.0	1.6	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.1	0.3	3.3	0.7	0.2	5.0	1.5	0.0	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.4	0.1	0.3	0.2	0.3	0.0	6.0	0.1	8.3	0.3	0.5	0.6	0.3	0.0	0.2	0.3	0.0	0.2	6.6	2.1	1.4	0.0	7.6	6.4	4.8	0.4	1.1	0.0	0.0	12.9	0.4	0.5	0.6	0.5	0.5	0.6	0.6	0.6	0.0	1.1	0.0
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;HUVEC TERT2: 4.9;LHCN-M2: 7.5;TIME: 17.0;U-2197: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	4.9	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.4	0.0	9.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	940000	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.5;NB-4: 17.7;RT4: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.3	1.0	0.5	0.6	2.3	4.7	0.6	0.3	1.4	0.1	0.5	2.7	0.4	0.8	3.2	0.0	0.5	0.1	6.1	1.0	0.6	1.0	0.1	2.0	24.5	1.8	3.4	0.3	7.3	1.3	1.4	1.7	0.0	0.2	3.8	0.4	0.2	0.2	17.7	1.2	0.6	0.5	6.3	0.7	0.1	10.8	0.4	0.3	0.2	1.0	0.6	0.9	3.5	1.8	2.3	3.1	5.2	0.5	0.7	2.0	1.4	3.6	2.4	4.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.6;HMC-1: 2.7;RH-30: 3.4;U-2 OS: 9.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HMC-1: 8.0;U-266/70: 12.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"														"Secreted to blood"						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5										
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;lung: 17.5"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		42000	42000	Mitochondria	Mitochondria	"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.9	1.7	0.8	11.3	1.1	5.7	0.8	0.2	1.1	1.3	5.0	0.6	1.2	4.6	1.7	0.4	1.8	1.5	1.4	2.6	1.1	0.5	1.3	0.8	17.5	4.0	1.3	0.2	1.0	2.3	0.0	0.8	0.5	1.1	1.6	3.2	0.7	2.1	1.3	0.5	1.8	10.9	1.6	2.0	7.8	1.8	0.9	1.2	6.4	0.9	2.4	7.4	2.4	1.8	0.1	12.2	33.7	17.4	0.0	1.2	2.5	0.4	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.2	1.8	0.1	0.0	0.0	1.0	0.1	0.8	0.0	0.0	0.1	24.7	0.3	1.2	0.0	0.1	0.2	0.1	0.6	0.1	1.5	0.0	2.8	0.8	0.0	0.0	0.5	0.0	0.6	0.6	0.4	0.6	0.4	0.5	0.3	0.9	0.6	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.7	1.9	1.5	0.0	7.6	33.7	0.1	10.0	0.7	0.1	0.2	1.2	12.2	0.0	0.3	1.2	0.3	0.0	17.4	0.0	1.1	2.5	0.8	1.1	0.2	1.1	1.1	0.5	1.3	0.2	1.1	1.2
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 23.9;placenta: 56.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4;HHSteC: 22.3;U-251 MG: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 8.4;T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB076385	Enhanced									"CAB076385: AB_2687655"	"prognostic favourable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favourable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	3.4	2.1	1.7	10.8	3.2	1.4	2.2	2.5	3.3	2.0	2.3	2.5	2.8	2.6	1.7	2.4	3.0	1.9	4.3	9.5	1.4	3.7	3.0	3.6	23.9	6.4	2.3	0.7	1.7	2.7	3.8	7.4	56.0	3.2	2.9	2.2	3.3	1.7	1.6	4.3	1.3	2.7	2.3	2.4	12.8	1.9	1.2	1.0	11.6	3.7	2.1	5.8	3.1	1.9	0.9	0.0	8.4	0.1	0.4	2.4	0.7	5.8	0.1	0.0	0.2	0.0	0.0	0.0	11.7	9.9	3.0	4.1	0.0	1.9	0.0	0.2	0.3	0.2	0.0	5.0	9.7	33.4	0.0	3.3	0.1	0.0	22.3	0.0	0.0	0.2	0.0	6.1	9.1	5.7	0.0	1.1	9.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.3	0.6	0.1	0.0	0.1	0.1	0.9	0.7	0.0	0.1	10.7	6.3	2.0	0.1	37.0	0.2	0.1	0.1	2.1	0.1	0.0	8.4	0.1	0.3	1.2	0.1	2.1	0.9	2.4	1.8	0.0	0.2	1.3	0.7	5.7	0.4	0.0	0.0	1.1	0.7	1.7	3.2	2.5	3.3	1.4	3.7	2.3	0.7	3.2	1.0
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;Daudi: 9.9;WM-115: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Low region specificity"	"Detected in many"							HPA011218	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.7	1.4	2.7	2.6	0.2	0.7	0.6	0.3	0.2	0.0	0.1	9.9	0.0	0.5	0.1	1.8	0.0	0.3	0.8	1.2	0.0	0.2	0.7	0.0	0.1	0.4	0.9	0.3	0.5	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.7	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.8	0.0	0.7	0.5	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.2	0.2	0.3	6.7	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2
CEACAM6	"CD66c, NCA"	ENSG00000086548	"Carcinoembryonic antigen related cell adhesion molecule 6"	P40199	19	41750977-41772208	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 81.4;gallbladder: 75.7;lung: 129.1"	"Cell line enriched"	"Detected in some"	8	"A549: 57.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.6;monocytes: 1.3"									"CAB008370, HPA011041"	Enhanced					79000000	79000000			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	0.3	0.3	0.3	7.4	0.3	29.7	0.3	0.3	0.3	16.8	35.3	0.2	0.1	5.8	0.9	0.2	81.4	1.1	75.7	2.3	0.3	0.3	0.3	0.8	129.1	0.1	0.3	0.1	0.3	1.7	0.0	0.3	32.1	0.2	0.9	43.1	0.2	50.1	0.1	0.3	2.1	12.8	0.9	0.3	0.8	2.6	0.3	0.1	1.0	0.3	25.3	58.1	2.3	21.0	0.1	0.3	2.6	1.3	0.1	0.3	5.2	0.0	57.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	1.5	0.0	0.2	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.1	0.5	0.3	0.0	5.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254103-38256369	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 63.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.0;HUVEC TERT2: 92.2;TIME: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"myeloid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		3600000	3600000	"Endoplasmic reticulum, Golgi apparatus"	"Endoplasmic reticulum, Golgi apparatus"	"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	32.2	3.9	3.2	6.8	4.3	0.0	47.8	2.3	3.9	14.5	9.3	3.4	5.9	5.9	18.4	13.3	9.3	9.9	13.6	23.7	3.8	3.4	6.8	11.4	63.2	7.9	4.9	2.2	7.6	3.3	5.0	2.8	15.0	4.4	11.8	4.4	10.8	5.5	6.5	36.5	6.5	7.4	12.1	3.9	9.0	5.9	6.8	2.2	1.4	14.0	21.1	3.8	9.4	14.8	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.3	2.3	3.9	3.8	3.4	4.9	2.2	4.4	2.2
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 50.0;ASC TERT1: 99.6;U-2197: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	46000000000	46000000000			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (1.53e-4)"	"prognostic favourable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favourable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	50.0	99.6	0.0	6.5	10.3	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	20.1	0.0	0.2	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5
CLEC4A	"CD367, CLECSF6, DCIR, DDB27"	ENSG00000111729	"C-type lectin domain family 4 member A"	Q9UMR7	12	8123632-8138607	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lung: 30.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6"									HPA007842	Uncertain									"HPA007842: AB_1078534"	"unprognostic (9.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.34e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.79e-2)"	8.3	2.0	2.7	20.1	4.0	14.6	3.3	2.2	2.6	3.7	3.1	3.5	0.6	3.6	2.7	5.2	2.1	2.9	5.6	3.4	2.5	2.5	5.4	4.1	30.0	25.1	2.8	2.4	5.5	2.5	0.5	3.3	6.0	3.2	4.1	4.6	4.0	2.6	2.2	2.2	3.8	4.7	3.3	8.1	16.3	2.0	2.8	3.7	5.7	2.8	3.2	7.4	6.0	3.1	4.5	53.2	48.8	54.6	0.5	0.2	23.7	0.3	0.0	0.7	1.8	3.4	8.4	1.1	2.2	1.0	1.8	2.5	3.0	1.5	1.3	0.3	1.2	0.4	1.9	0.4	1.1	2.2	2.3	1.4	1.5	0.8	4.2	4.2	5.7	4.2	1.9	0.7	2.4	0.4	0.8	1.2	2.4	1.0	1.2	3.2	1.3	0.8	0.8	1.5	2.1	1.2	2.0	0.3	0.7	0.5	1.6	0.0	0.2	0.3	0.5	3.2	1.9	1.2	1.4	1.5	0.2	1.7	0.4	1.6	0.1	29.2	54.6	0.1	0.1	31.2	0.1	2.0	0.1	0.2	53.2	4.5	0.1	0.1	48.8	0.5	19.6	7.3	0.1	23.7	2.7	4.0	2.2	2.6	2.5	2.5	2.8	2.4	3.2	3.7
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;SH-SY5Y: 1.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045239	Uncertain				"Secreted to extracellular matrix"	490000	490000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	2.3	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0			0.0	0.7	0.3	1.2	0.3	0.0	5.6	0.0	0.0	0.0	0.9	11.1	0.0	0.0		0.2	0.0	0.0	5.7	0.8		0.0	0.0		2.2	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0										
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;HUVEC TERT2: 8.7;SCLC-21H: 5.8;SK-MEL-30: 9.6;TIME: 11.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"	360000000	360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favourable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.2	5.8	1.3	0.7	0.0	9.6	0.1	0.0	11.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	3.5	0.0	0.7	0.0	0.1	0.0	3.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.5;U-87 MG: 76.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	3.1	2.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	10000000	10000000	"Vesicles, Cytosol, Cytoplasmic bodies"	"Vesicles, Cytosol, Cytoplasmic bodies"	"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.0	1.1	0.4	4.7	1.1	0.0	5.2	1.6	0.6	2.8	1.5	7.0	42.5	5.6	1.7	0.1	31.0	2.0	7.7	2.3	23.6	0.1	0.1	0.2	16.2	1.6	0.0	1.0	0.8	2.2	0.0	0.0	0.2	11.4	0.0	3.8	1.7	3.6	9.8	1.2	0.3	0.0	0.3	0.9	9.8	118.0	0.5	1.1	6.9	3.9	9.6	1.5	5.3	2.2	0.0	1.0	0.0	0.7	0.1	12.2	3.1	0.0	10.3	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;BJ hTERT+ SV40 Large T+: 3.6;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Daudi: 3.1;RPMI-8226: 6.6;RT4: 3.7;THP-1: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favourable (1.12e-5)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.6	3.6	3.5	0.3	0.1	3.1	0.4	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.1	3.7	0.0	0.0	0.0	0.7	2.1	0.2	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428288-42443048	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.0;lung: 83.0;stomach 1: 79.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 2.1;RT4: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favourable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.7	0.1	0.1	17.4	0.1	0.4	0.1	0.0	1.0	5.1	68.0	6.3	1.3	0.1	0.1	0.0	0.7	0.4	83.0	0.1	0.1	0.1	2.8	11.4	0.0	2.3	0.1	0.3	6.8	0.0	0.3	39.2	0.5	0.1	0.0	0.1	0.3	0.1	0.1	79.9	0.3	0.1	0.5	1.2	8.8	40.1	5.5	10.0	0.0	0.0	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 22.8;hTEC/SVTERT24-B: 35.8;RPTEC TERT1: 20.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"																"Secreted to blood"						"unprognostic (2.12e-3)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.6	0.0	2.5	22.8	0.6	1.4	0.0	2.7	0.0	2.5	0.0	0.1	0.1	0.8	5.0	0.0	0.0	1.8	0.2	0.0	2.8	0.2	0.0	0.5	0.6	35.8	3.5	0.5	0.4	0.0	1.0	0.0	0.5	0.1	0.3	0.7	0.0	0.8	0.0	20.6	0.6	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.9	5.1	0.2	2.5	6.3	0.0	0.0	0.0	5.7	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Cell line enhanced"	"Detected in some"		"A549: 33.7;EFO-21: 28.4;HSkMC: 20.5;hTEC/SVTERT24-B: 14.7;RPTEC TERT1: 108.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"									HPA065474	Approved				"Secreted to blood"					"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	33.7	0.1	0.0	0.0	1.2	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	28.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.5	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in some"	5	"Daudi: 16.1;NB-4: 19.4;REH: 16.5;RPMI-8226: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA051227	Enhanced					640000	640000			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.4	0.0	0.1	16.5	0.0	63.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.7	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.2;ASC TERT1: 25.9;HSkMC: 103.9;SiHa: 48.4;U-87 MG: 26.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.0	0.4	0.0	24.2	25.9	0.0	0.1	0.8	0.2	2.3	0.0	5.4	0.0	3.5	3.2	10.6	0.0	0.7	0.4	0.9	0.7	0.0	3.9	0.0	6.6	0.0	0.0	103.9	10.1	5.6	0.2	0.0	0.1	0.0	0.1	5.1	0.0	3.9	1.4	2.5	0.0	0.0	0.0	2.4	0.1	0.1	0.4	48.4	7.0	0.0	9.0	1.9	0.0	0.1	0.0	19.8	0.0	0.0	0.0	0.0	26.4	0.0	2.1	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2										
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Cell line enriched"	"Detected in some"	8	"RT4: 79.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.1;fallopian tube: 26.6;lung: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;TIME: 3.8;U-266/70: 1.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain									"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	11.1	0.0	26.6	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	5.5	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.0	0.6	0.1	0.2	0.3	0.0	0.1	0.9	1.6	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.3	0.4	0.0	0.0	0.6	0.2	0.8	0.1	3.8	0.1	0.8	1.1	0.7	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123936206	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 4.0;ASC TERT1: 1.7;U-87 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.8;pons and medulla: 10.0"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.6;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"									HPA039066	Enhanced									"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.4	0.2	0.7	0.2	4.8	3.1	0.3	1.2	0.6	1.9	0.7	3.9	0.5	0.5	0.6	10.1	0.2	9.5	0.2	0.2	1.4	1.7	0.4	0.2	11.8	0.2	0.5	0.0	6.2	0.2	0.1	0.2	0.4	10.0	1.1	0.2	0.0	0.2	0.2	0.1	0.2	1.1	0.2	1.5	0.3	0.2	16.4	0.3	0.0	0.5	0.0	0.2	0.4	0.9	0.1	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.1	2.3	4.0	1.7	0.6	1.0	0.3	0.0	0.2	0.0	0.5	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	1.1	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.8	0.0	0.2	0.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	4.8	1.2	0.5	1.4	1.7	0.5	0.0	10.0	0.3
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;LHCN-M2: 2.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enriched"	"Detected in many"	8	"pons and medulla: 23.0"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA037493, HPA058203, HPA061365"	Enhanced									"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.2	0.3	0.6	0.1	3.0	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0.0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0.0	7.6	3.1	0.1	8.9	0.1	23.0	0.2	0.2	0.0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.0	1.2	0.9	0.1	0.3	0.7	0.0	0.0	0.9	0.3	0.1	0.0	0.2	0.3	0.0	3.1	0.3	0.1	0.0	0.4	0.4	0.0	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.1	0.4	0.2	0.2	0.1	2.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.9	0.1	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.0	0.5	0.0	0.1	0.6	3.0	0.2	0.3	2.9	0.8	0.4	0.0	23.0	1.0
DPPA3	"Pgc7, Stella"	ENSG00000187569	"Developmental pluripotency associated 3"	Q6W0C5	12	7711454-7717559	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;lung: 2.1;ovary: 1.8;testis: 3.6"	"Group enriched"	"Detected in some"	216	"BEWO: 84.5;NTERA-2: 35.5"	"Cancer enriched"	"Detected in single"	779	"testis cancer: 339.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	17	"dendritic cells: 2.3;granulocytes: 1.7"																																	"unprognostic (2.52e-1)"	"unprognostic (9.49e-2)"			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	3.6	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877351-102012130	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"breast: 52.5;lung: 73.9"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.19e-2)"	"prognostic favourable (6.52e-8)"	"unprognostic (1.15e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.07e-2)"	13.1	11.0	3.6	9.9	3.8	16.7	52.5	1.2	2.6	9.2	8.3	2.3	3.6	3.4	8.0	9.2	8.1	6.9	11.2	13.8	3.6	3.6	16.7	7.2	73.9	20.9	4.3	2.3	10.9	13.7	4.3	6.6	15.2	4.4	13.2	4.8	5.4	8.8	5.4	6.6	4.6	6.4	10.8	4.4	14.8	10.0	8.6	2.2	4.9	10.4	4.3	6.4	12.4	22.1	2.6	3.0	9.2	9.8	3.5	2.2	2.5	1.9	3.9	1.4	0.4	18.4	4.2	7.8	14.6	101.3	14.7	23.1	1.3	3.8	0.3	1.7	24.0	2.9	0.3	6.0	20.5	2.1	1.2	0.5	3.5	5.0	8.5	0.5	1.1	5.0	2.7	5.1	5.6	7.9	1.7	0.7	3.8	1.5	0.3	1.7	1.0	0.9	0.6	1.0	0.3	15.6	9.3	0.3	0.3	8.1	0.9	3.8	2.8	2.2	4.8	10.4	1.8	1.8	2.6	2.1	0.9	0.2	3.5	5.0	2.7	9.2	8.8	5.8	1.9	9.8	2.2	2.6	1.4	2.0	3.0	1.7	1.1	1.3	8.8	3.5	5.6	0.8	1.9	2.5	3.6	3.8	1.2	2.4	3.6	3.6	4.3	2.3	4.4	2.2
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281622-36345756	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.6;fallopian tube: 20.6;lung: 18.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 6.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"	0.7	0.5	1.9	5.8	14.8	0.9	0.4	0.3	0.3	2.1	1.1	2.8	1.4	0.7	1.1	11.9	0.7	20.6	3.5	0.4	3.1	2.9	0.4	0.7	18.5	5.4	0.4	0.0	8.1	0.3	0.2	0.8	0.2	16.6	0.5	0.7	0.1	0.6	0.3	0.2	0.2	1.3	0.4	0.7	8.0	0.8	2.2	4.5	0.0	0.6	1.2	4.0	3.1	0.5	0.0	0.0	0.1	0.0	1.1	6.8	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.1	6.8	0.0	1.2	0.0	0.6	2.1	0.0	0.0	0.0	2.6	0.0	1.1	0.0	0.0	0.0	0.7	1.9	14.8	0.3	0.2	3.1	2.9	0.4	0.0	16.6	4.5
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 48.7"	"Group enriched"	"Detected in some"	5	"HaCaT: 33.8;hTCEpi: 16.4;RT4: 18.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 17.5"	HPA023544	Approved									"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favourable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	0.4	5.2	0.5	0.4	0.8	0.0	2.0	1.2	0.9	18.9	0.6	2.4	43.3	0.1	2.2	37.8	38.3	6.0	6.2	1.1	0.6	0.1	0.2	0.1	48.7	0.1	1.0	0.5	1.2	0.1	1.8	0.9	2.5	0.9	4.8	0.0	4.3	9.8	19.2	0.8	34.2	0.3	1.6	0.5	0.1	18.0	1.0	1.1	0.7	31.9	35.9	31.9	6.2	13.1	0.2	1.5	0.5	0.5	0.1	0.4	0.0	4.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	33.8	0.0	3.2	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	16.4	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	18.9	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.3	0.0	1.1	0.2	0.2	0.0	0.0	0.1	0.1	1.5	0.2	0.0	0.5	0.8	1.2	0.9	0.6	0.1	1.0	0.5	0.9	1.1
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580698	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 58.3;RT4: 40.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014711	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA014711: AB_1848147"	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	16.5	2.0	5.0	7.9	5.1	0.0	26.2	3.4	4.7	14.8	10.4	3.4	6.1	4.2	7.3	13.8	35.7	7.4	7.3	14.0	5.5	3.0	3.1	47.5	118.7	5.7	5.4	2.5	14.0	3.2	19.9	3.2	23.5	5.3	11.1	10.0	10.8	9.9	5.8	7.7	40.2	6.6	12.8	3.4	5.3	9.3	5.6	4.1	2.2	7.5	26.4	18.4	10.6	16.3	1.3	1.1	4.1	1.1	1.4	1.0	0.4	6.2	8.6	3.6	4.2	8.1	7.0	7.1	8.9	8.2	5.4	8.2	28.2	21.9	0.0	2.8	10.6	27.8	9.2	11.0	7.1	0.0	5.8	0.0	18.1	15.4	1.4	0.0	0.0	4.2	2.9	7.2	0.7	2.2	2.0	0.5	14.9	58.3	0.1	0.1	4.1	2.1	1.6	4.1	13.6	1.2	40.1	5.0	5.7	11.0	57.6	3.3	35.2	1.3	1.2	17.3	7.5	5.7	4.9	0.1	0.2	0.0	7.6	0.1	16.9	3.4	1.0	1.0	0.8	0.8	1.0	1.0	0.8	0.7	0.5	1.3	0.9	0.9	4.1	1.4	1.1	1.1	0.8	0.4	5.0	5.1	3.4	4.7	5.5	3.0	5.4	2.5	5.3	4.1
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.9;HHSteC: 57.5;RT4: 56.9;TIME: 56.7;U-138 MG: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.2	5.6	0.3	0.4	27.0	17.4	45.9	16.6	45.2	9.5	10.4	0.9	0.9	0.0	4.1	31.5	2.5	0.1	13.3	7.1	0.1	0.2	0.0	1.8	11.7	57.5	0.0	3.4	25.5	18.3	18.6	13.1	32.7	0.5	0.0	5.8	4.5	0.1	0.1	0.2	3.1	0.1	0.6	1.7	5.9	56.9	0.2	11.8	13.0	29.9	3.6	2.0	2.3	56.7	49.3	1.4	6.5	1.3	0.0	0.0	0.0	36.0	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.3"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain									"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7
FAM92B	FLJ44299	ENSG00000153789	"Family with sequence similarity 92 member B"	Q6ZTR7	16	85098358-85112508	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.2;fallopian tube: 50.7;lung: 13.8"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 7.4;TIME: 2.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA041022	Enhanced									"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	0.9	2.0	0.7	8.3	0.3	0.3	0.7	0.6	2.0	0.5	6.3	0.0	0.9	0.9	10.8	0.1	50.7	0.2	0.1	2.7	5.0	0.1	0.1	13.8	0.3	0.0	0.0	8.8	0.1	0.1	13.5	0.1	14.2	0.2	0.4	0.0	0.3	0.2	0.1	0.3	0.5	0.1	0.4	0.6	0.3	0.7	1.8	0.0	0.1	0.0	1.2	1.3	0.0	1.2	0.2	0.9	0.3	2.5	0.4	0.2	0.4	0.0	0.5	0.3	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.4	0.3	0.6	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.5	0.2	0.1	0.5	0.2	0.3	0.4	7.4	0.9	0.0	0.1	0.2	0.7	0.7	2.2	0.6	0.5	0.1	0.2	0.2	0.2	0.4	0.4	0.2	1.6	0.1	0.2	0.1	0.4	0.3	0.2	1.2	0.2	0.1	0.2	0.3	0.2	0.2	0.9	2.5	0.1	0.2	0.0	0.2	2.0	8.3	0.7	0.6	2.7	5.0	0.0	0.0	14.2	1.8
FBN3		ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149846	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 5.2;salivary gland: 7.5"	"Group enriched"	"Detected in some"	4	"NTERA-2: 12.4;REH: 17.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA049482	Uncertain				"Secreted to extracellular matrix"					"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	1.0	0.2	1.2	0.0	0.5	0.2	2.4	0.2	0.2	2.8	0.2	0.0	0.7	0.2	0.5	1.8	0.2	0.2	1.0	1.1	3.6	0.5	5.2	0.2	2.4	0.2	0.8	0.2	0.0	1.9	0.2	2.1	1.7	0.3	0.2	7.5	0.2	0.9	0.6	0.3	0.3	2.0	0.2	0.1	1.1	1.7	0.8	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.4	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.2	2.4	1.0	1.1	2.4	0.2	2.1	1.7
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 20.1;MCF7: 62.8;RT4: 41.2;SK-BR-3: 12.0;U-698: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Uncertain	Mitochondria		23000000	23000000	Mitochondria	Mitochondria	"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	62.8	0.0	1.1	0.2	2.2	0.0	0.2	0.4	0.0	41.2	0.2	1.2	0.1	12.0	0.0	7.2	1.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	29.9	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874248-54890472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.6;neutrophil: 6.1"	"Group enriched"	"Detected in many"	44	"granulocytes: 6.1;monocytes: 2.6"					"Low region specificity"	"Detected in many"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.0	0.6	0.4	1.5	4.4	28.1	0.8	0.1	1.0	0.6	0.6	0.7	0.0	0.6	0.6	0.6	0.6	3.8	0.6	8.2	2.0	0.4	0.6	1.8	19.5	15.9	1.2	0.0	2.2	0.6	0.6	0.3	1.5	4.3	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.6	0.7	2.7	14.9	0.9	2.1	0.0	1.0	0.6	0.3	0.6	4.4	4.8	0.0	0.0	6.1	2.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.7	0.4	4.4	0.1	1.0	2.0	0.4	1.2	0.0	4.3	0.0
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in some"	57	"ASC diff: 24.0;ASC TERT1: 10.9;HSkMC: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA028261	Approved									"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3
FO681492.1		ENSG00000277758			10	47750864-47763592	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 5.2;brain: 6.7;lung: 10.6"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 36.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.2"	"Low lineage specificity"	"Detected in many"											"HPA036971, HPA036972, HPA064559"	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"	"unprognostic (2.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-5)"	"unprognostic (4.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.11e-2)"	0.5	0.0		0.1		0.0	0.0		6.7	0.3	0.0			0.0	0.1	0.0	2.4	1.1	0.4	0.4			0.0	0.0	10.6	2.3			0.3	1.4	0.0		1.1		0.0	0.0		1.4	0.4	0.0	3.4	0.0	0.0		0.2	0.0	0.0			0.0		0.5	0.9		0.7	2.5	0.4	5.2	0.9	1.1	0.4	0.5	4.1	0.0	0.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	2.6	2.9	0.0	0.2	1.1	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.2	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	3.2	36.1	0.1	3.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.3	2.3	0.3	0.7	2.8	1.1	0.7	1.1	0.8	2.5	0.3	0.5	0.7	0.4	0.9	5.2	1.0	0.7	0.4										
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix protein 2"	Q5SZK8	13	38687129-38887131	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 13.9;lung: 11.2;thyroid gland: 12.2"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.4;MCF7: 7.5;RT4: 7.0;SK-BR-3: 6.3;WM-115: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028831	Uncertain		Approved	Cytosol		170000	170000	Cytosol	Cytosol	"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.6	0.4	1.3	0.1	1.7	0.1	0.5	1.5	6.4	0.7	1.3	1.2	1.1	0.4	1.1	0.5	0.2	0.9	1.5	0.2	2.8	0.4	13.9	3.4	11.2	0.1	0.4	0.8	1.8	5.2	0.1	1.1	2.6	0.8	3.5	0.4	2.9	0.4	1.5	6.3	0.6	0.7	0.7	0.4	0.3	2.2	1.8	1.5	0.1	12.2	4.1	0.1	1.5	0.3	0.3	0.3	0.9	0.2	0.2	0.2	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.3	0.2	0.0	1.5	0.1	2.4	7.0	0.2	0.1	0.0	6.3	0.3	1.1	0.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.8	0.9	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.7	0.2	0.2	0.3	0.1	0.0	1.3	1.7	1.5	6.4	2.8	0.4	0.4	0.8	0.8	1.5
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1										
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 4.2;salivary gland: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;HDLM-2: 1.4;RH-30: 1.4;SH-SY5Y: 1.3;U-2 OS: 1.6;U-2197: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534"	Uncertain									"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.9	0.0	4.2	0.0			0.0	0.9	0.0		0.0		0.0	0.0		3.0	0.0	0.0	0.0	1.2	0.0		0.0	0.7	1.5			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.6	0.0	0.0	1.4	0.3	0.0	0.9	0.8	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.6	4.3	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12890782-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 155.0"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 161.0;HaCaT: 42.2;SiHa: 59.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 3.1"	"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	9.8	1.4	0.2	6.0	0.6	0.4	5.4	0.1	0.3	12.1	19.8	0.5	2.0	6.2	4.3	1.9	9.1	3.0	15.5	7.1	0.1	0.2	5.1	0.6	155.0	0.1	0.5	0.1	18.5	1.1	0.0	0.9	20.1	3.1	10.4	16.9	4.8	9.6	1.5	1.1	2.0	36.9	14.2	1.1	0.1	11.4	4.8	0.3	0.1	54.2	14.9	11.5	32.1	14.0	0.6	0.6	3.1	0.3	0.5	0.4	0.0	41.8	33.5	0.0	0.1	0.4	0.2	2.1	12.6	4.8	8.2	6.3	5.8	161.0	0.0	1.0	10.0	42.2	0.1	6.1	12.6	0.0	0.5	0.0	13.8	0.2	3.0	0.0	0.0	0.2	8.2	3.4	0.8	5.0	0.0	0.0	0.3	29.3	0.0	0.0	0.1	5.2	0.0	0.9	0.0	16.3	8.3	0.0	0.0	59.2	4.5	1.9	1.3	0.1	0.5	0.3	10.7	19.2	0.5	0.0	0.0	0.0	4.3	0.0	0.2	3.1	0.3	0.4	0.3	0.2	0.3	0.3	0.2	0.3	0.1	0.6	0.4	0.4	1.3	0.5	0.2	0.6	0.3	0.0	0.2	0.6	0.1	0.3	0.1	0.2	0.5	0.1	3.1	0.3
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.9;lung: 10.5;skin 1: 13.8"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;A549: 27.8;SiHa: 5.2;SK-BR-3: 15.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA038129	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038129: AB_2675846"	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.0	0.0	0.0	0.6	0.2	0.0	1.1	6.5	0.0	0.2	5.7			6.6	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.2	1.7	0.0	10.5	0.0	1.2		0.0	4.1	0.0	3.0	0.0		1.6	4.0		4.2	1.5	0.0	13.8	8.9	0.0	0.2	0.0	5.1	1.3			2.3		0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.4	0.6	0.1	5.2	15.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220168-59230774	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.6;pituitary gland: 13.2;retina: 22.5"	"Group enriched"	"Detected in some"	12	"BJ hTERT+: 8.4;fHDF/TERT166: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8"						"Secreted to blood"						"unprognostic (3.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.01e-3)"		"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.86e-4)"	"unprognostic (2.65e-4)"	"unprognostic (9.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.16e-2)"	0.7	0.7	3.6	0.5	0.7	0.2	5.2	0.5	3.7	0.5	2.3	1.3	0.0	0.4	0.9	0.9	0.6	0.3	1.3	0.2	11.7	5.6	0.3	0.2	15.6	0.2	4.9	0.7	0.2	4.7	4.7	13.2	0.2	10.5	1.9	0.4	22.5	0.2	0.5	0.2	0.4	0.7	2.3	1.6	0.3	12.7	3.0	0.1	0.1	11.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	0.7	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.5	3.7	11.7	5.6	4.9	0.7	10.5	0.1
GSAP	"LOC54103, PION"	ENSG00000186088	"Gamma-secretase activating protein"	A4D1B5	7	77310751-77416400	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lung: 33.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.2;U-937: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023994			Supported	Vesicles				Vesicles	Vesicles	"HPA023994: "	"prognostic favourable (3.36e-4)"	"unprognostic (3.70e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.53e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.36e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (9.49e-2)"	"prognostic favourable (4.15e-5)"	5.7	6.3	3.8	19.9	3.9	7.0	5.7	1.7	6.6	3.5	6.4	4.4	2.8	2.0	3.9	6.7	5.0	5.7	8.0	7.3	4.2	5.4	6.2	13.9	33.1	24.0	4.5	2.2	4.0	5.4	9.4	14.0	3.6	4.2	5.8	4.1	5.6	5.6	5.3	2.5	3.7	10.1	8.0	5.5	21.5	6.9	1.9	3.3	3.8	9.4	3.4	14.8	5.5	3.4	13.7	11.7	1.3	9.7	11.2	6.6	5.7	3.2	1.7	0.0	0.0	0.5	2.2	0.3	2.0	6.8	1.1	2.9	0.5	4.7	0.7	0.2	0.0	1.6	0.1	1.6	3.0	2.1	1.3	3.5	0.2	9.0	3.0	0.3	0.0	0.8	6.2	5.5	11.2	0.5	0.0	0.3	9.1	1.8	0.0	6.9	0.5	2.4	0.0	0.1	0.1	6.1	2.7	0.2	5.1	2.2	1.1	5.3	2.0	2.9	0.0	1.7	1.2	0.2	6.1	1.3	0.0	1.2	7.9	14.7	1.4	0.0	9.7	0.9	6.6	8.9	3.9	13.7	2.2	4.5	11.7	12.3	2.9	4.8	1.3	11.2	6.4	0.3	0.1	5.7	3.8	3.9	1.7	6.6	4.2	5.4	4.5	2.2	4.2	3.3
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 2.9;lung: 2.2;skin 1: 2.0"	"Group enriched"	"Detected in some"	8	"HAP1: 5.1;HEK 293: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain									"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.5	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646021-144745271	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;lung: 29.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 68.2;TIME: 78.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA012616: "	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	4.0	5.2	9.9	1.7	22.2	2.3	1.1	2.3	16.0	3.4	6.5	31.5	0.0	5.5	4.1	8.1	1.0	1.2	3.0	1.1	16.0	6.3	2.4	12.7	29.7	1.0	21.6	9.9	2.2	4.8	1.0	1.1	1.0	17.5	9.8	6.8	4.4	1.3	6.2	1.3	1.1	8.2	1.3	12.3	1.0	11.2	3.7	26.5	2.3	1.6	0.0	1.0	7.1	1.0	0.1	2.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.6	68.2	0.0	0.0	1.0	0.0	9.6	0.0	0.9	0.6	0.1	13.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.7	0.0	0.8	0.0	0.5	0.4	0.0	2.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.0	9.9	22.2	2.3	16.0	16.0	6.3	21.6	9.9	17.5	26.5
HIST1H4K	"dJ160A22.1, H4/d, H4F2iii, H4FD"	ENSG00000273542	"Histone cluster 1 H4 family member k"	P62805	6	27831216-27831527	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lung: 2.9;lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	5	"HHSteC: 2.8;LHCN-M2: 2.8;RT4: 1.6;U-87 MG: 1.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	0.7	0.0	1.0	3.1	3.4	0.0	0.0	0.7	2.0	0.4	0.6	0.3	0.0	0.0	0.0	0.5	2.1	0.0	1.3	0.0	0.3		0.1	0.0	2.9	2.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.7	1.1	0.0	0.9	0.0	2.1	0.5	2.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0										
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741342-32747215	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.7;lymphoid tissue: 51.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	6.1	2.7	0.5	1.5	0.5	1.5	3.6	0.0	1.5	6.3	1.8	2.1	0.0	1.5	3.8	1.5	2.5	1.9	27.2	16.5	1.0	0.9	12.5	3.5	37.7	43.6	1.3	0.6	1.5	1.5	1.5	1.5	1.9	3.0	7.9	1.5	6.5	19.9	2.5	1.5	4.7	11.7	1.5	5.9	35.5	2.3	1.5	0.0	40.5	3.5	6.7	51.1	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.2	1.0	0.9	1.3	0.6	3.0	0.0
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	"P01911, P04229, Q29974, Q9GIY3"	6	32578769-32589848	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.6;lung: 95.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 154.0;HMC-1: 21.9;U-266/70: 20.5;U-698: 26.5;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 95.6"	"Group enriched"	"Detected in all"	10	"B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5"									"CAB015400, CAB034021, HPA043151"	Enhanced									"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	36.8	18.7	9.7	32.2	15.9	8.7	24.9	3.6	10.0	14.2	18.2	11.5	11.2	0.2	10.5	27.2	12.1	13.3	12.0	11.9	8.5	6.9	50.0	15.6	95.9	80.8	18.9	5.4	6.9	8.0	0.0	9.4	5.7	14.8	9.5	23.7	16.1	11.3	2.4	8.2	13.3	42.1	3.8	19.7	62.1	38.1	5.6	13.2	33.6	14.1	3.8	44.7	29.7	17.0	41.3	95.6	6.3	52.5	2.7	4.7	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.2	0.0	0.6	0.0	154.0	1.7	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.6	18.5	0.0	0.0	0.1	0.2	0.0	20.5	0.5	26.5	42.5	0.7	0.0	0.2	34.6	6.3	1.8	52.5	0.3	32.7	1.2	3.7	95.6	41.3	0.1	1.6	1.2	2.7	26.9	20.4	4.7	37.7	9.7	15.9	3.6	10.0	8.5	6.9	18.9	5.4	14.8	13.2
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517343-32530287	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 71.8;lymphoid tissue: 64.8"	"Group enriched"	"Detected in some"	5	"HDLM-2: 109.4;HMC-1: 27.7;U-698: 32.7;U-87 MG: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 26.4"	"Group enriched"	"Detected in many"	10	"B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0"									HPA043151	Supported									"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	21.8	14.2	2.9	22.1	3.9	3.7	16.2	2.0	3.2	16.7	21.7	7.0	6.4	2.3	8.7	22.1	9.5	12.6	6.6	9.1	4.3	4.0	32.2	9.3	71.8	60.4	7.3	0.8	4.9	4.9	0.0	6.0	4.9	5.4	9.5	10.2	11.2	9.0	2.7	7.4	8.8	34.7	4.7	12.2	64.8	40.3	4.6	4.5	15.3	9.5	11.2	27.6	21.8	6.5	13.3	26.4	1.5	16.0	0.9	1.8	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	109.4	1.1	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.6	0.0	0.6	0.1	0.3	0.0	7.4	0.1	32.7	43.2	0.3	0.0	0.0	10.1	1.5	0.4	16.0	0.0	10.5	0.4	1.1	26.4	13.3	0.0	0.5	0.3	0.9	8.1	5.9	1.8	15.4	2.9	3.9	2.0	3.2	4.3	4.0	7.3	0.8	5.4	4.5
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10270835-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.3;lung: 91.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 31.1;Karpas-707: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002126, CAB002142, HPA004877"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		3100000000	3100000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favourable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	26.1	8.6	4.0	41.0	4.1	36.5	15.0	1.0	4.5	5.6	10.0	2.7	1.6	6.1	8.5	7.7	7.9	10.7	19.8	16.3	2.6	2.1	10.9	68.3	91.3	32.8	5.4	1.7	12.4	7.2	2.5	4.0	9.3	6.8	10.4	6.6	10.6	7.2	3.6	13.9	6.9	7.9	8.0	7.8	42.2	7.3	6.5	3.6	8.3	11.6	13.7	13.4	14.8	17.1	2.2	13.3	22.2	14.2	7.9	5.6	8.9	8.2	0.1	1.5	0.0	0.4	0.9	2.1	1.7	18.5	4.1	12.5	2.7	9.3	7.6	25.8	0.7	1.7	0.3	0.0	8.7	22.7	0.0	0.7	0.2	11.3	31.1	0.2	4.5	10.9	0.7	2.6	4.0	2.1	2.8	88.5	0.3	0.6	0.1	6.4	0.5	4.7	0.2	0.0	28.1	7.0	0.0	0.0	0.2	11.4	0.6	18.1	1.4	0.5	6.4	4.2	0.4	2.3	0.1	27.0	27.8	4.7	6.8	4.9	6.2	2.2	13.9	2.6	3.0	14.2	5.6	2.2	2.4	3.6	13.3	0.9	1.0	2.2	22.2	7.9	7.9	7.5	3.4	8.9	4.0	4.1	1.0	4.5	2.6	2.1	5.4	1.7	6.8	3.6
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159747	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.4;lung: 14.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 2.2;U-698: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"gdTCR: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.6"					"Low region specificity"	"Detected in single"			CAB010344	Approved				"Secreted to blood"					"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	2.4	0.9	0.3	4.5	0.3	14.4	0.5	0.1	1.0	1.4	0.9	0.5	0.0	0.2	0.6	1.4	1.3	0.2	0.6	1.0	0.3	0.3	0.7	4.1	14.5	8.5	1.5	0.4	0.4	0.2	0.0	0.5	0.8	0.6	1.2	0.4	1.1	1.4	0.2	1.7	0.3	0.7	0.7	1.3	4.1	0.8	0.2	0.0	0.8	1.3	3.1	4.7	2.2	0.6	0.5	0.0	0.2	0.0	1.2	8.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.3	8.6	0.0	0.5	0.8	5.2	0.2	1.2	0.0	0.0	0.2	1.1	0.3	0.3	0.1	1.0	0.3	0.3	1.5	0.4	0.6	0.0
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398775	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.5;HHSteC: 29.2;HMC-1: 19.6;U-937: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 26.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	17.8	2.6	1.4	8.3	1.7	12.5	11.2	0.8	1.3	8.2	8.1	0.7	6.6	5.1	4.2	5.7	4.5	4.5	14.1	10.5	1.7	1.9	7.4	8.8	39.3	29.6	2.0	0.1	3.3	2.6	0.8	4.6	10.7	1.6	6.3	3.4	5.0	3.0	28.4	2.8	3.2	10.7	7.9	1.9	19.5	4.6	2.4	0.4	2.5	3.2	3.2	6.6	8.2	12.9	0.1	6.8	5.5	0.1	26.8	10.6	1.1	0.8	0.2	0.0	0.0	0.7	0.7	1.6	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.8	0.0	13.5	0.7	2.4	0.6	0.1	29.2	5.1	19.6	6.7	1.1	2.1	3.5	4.9	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.4	0.6	0.4	2.3	0.4	0.0	0.0	0.0	0.1	31.3	2.3	5.5	0.0	2.4	4.2	0.1	10.6	0.1	2.4	3.0	2.0	0.1	0.4	0.8	4.1	26.8	0.0	6.8	2.4	1.1	1.4	1.7	0.8	1.3	1.7	1.9	2.0	0.1	1.6	0.4
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 73.5"	"Group enriched"	"Detected in some"	5	"CACO-2: 18.2;HHSteC: 7.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA061343			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favourable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	19.7	18.0	0.3	3.0	0.7	0.0	5.9	0.3	0.6	4.9	3.7	1.3	14.0	0.8	9.8	18.9	12.4	16.3	14.7	24.6	0.6	0.4	11.8	24.3	73.5	12.1	1.1	0.8	20.2	4.0	0.7	3.2	12.9	2.5	10.1	1.6	13.0	6.1	19.9	4.7	1.5	3.9	11.3	1.3	6.5	5.0	28.2	0.2	0.5	9.4	3.8	2.8	9.6	6.4	1.7	1.1	4.2	1.0	2.2	1.0	0.6	0.0	0.1	0.1	0.1	1.8	2.5	0.4	0.2	2.3	0.0	0.0	18.2	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	7.8	0.1	0.3	0.9	0.0	0.0	0.1	0.4	0.1	0.3	0.3	0.1	0.0	0.4	0.8	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.1	0.7	0.0	0.2	0.1	1.1	0.1	0.8	0.3	0.1	0.8	0.3	0.1	0.2	0.1	0.3	4.2	1.0	0.8	0.7	0.4	0.7	1.2	0.7	0.6	0.4	1.7	1.0	0.8	3.0	2.2	0.4	1.1	0.6	0.6	0.3	0.7	0.3	0.6	0.6	0.4	1.1	0.8	2.5	0.2
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	39.8	0.0	2.2	1.5	23.9	2.3	1.3	2.0	1.5	4.7	0.0	0.0	0.0	4.4	13.5	0.0	9.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.2	0.9	8.1	0.0	0.0	0.0	1.4	7.7	0.0	0.0	4.4	0.0	0.0	2.5	0.0	8.9	0.0	1.5	0.0	7.8	16.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801243	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0"	"Cell line enriched"	"Detected in single"	21	"MOLT-4: 15.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB026461, HPA036313"	Approved					13000	13000			"CAB026461: , HPA036313: AB_10795355"	"unprognostic (9.81e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.86e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (8.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (3.56e-4)"	3.6	0.2	0.3	13.0	0.6	8.0	0.9	0.2	0.2	0.6	9.6	0.2	0.0	4.9	0.4	0.4	2.0	1.5	2.7	0.2	0.5	0.4	0.3	0.3	25.9	8.1	0.3	0.0	0.9	1.2	0.5	0.4	0.1	0.2	1.2	2.0	0.2	1.8	3.9	0.3	0.6	20.2	2.0	0.7	1.4	3.6	1.6	0.1	3.1	1.0	1.5	5.3	1.9	2.5	0.2	0.1	0.0	1.0	0.0	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	15.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	1.0	3.1	0.2	1.0	7.4	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.9	0.9	0.3	0.6	0.2	0.2	0.5	0.4	0.3	0.0	0.2	0.1
ITGAX	CD11c	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382997	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004458, HPA004723, CAB072871"	Enhanced									"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	47.9	1.9	4.4	28.1	5.7	28.6	2.9	1.4	4.4	1.8	2.1	17.1	0.6	1.7	2.1	2.5	1.9	4.3	7.7	2.5	5.3	4.6	2.3	4.6	33.2	24.4	13.6	3.8	3.0	2.1	0.8	2.4	3.3	8.1	2.5	3.2	2.5	4.3	1.3	1.1	1.6	3.8	3.3	15.6	46.3	3.3	0.9	7.5	3.8	2.2	0.9	9.7	5.1	1.9	0.8	12.4	31.7	20.3	14.9	1.8	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.1	0.1	0.0	0.4	48.1	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.1	3.9	10.1	9.2	1.8	18.1	0.1	0.8	0.0	0.3	12.4	0.4	0.0	0.2	31.7	14.9	20.3	0.2	0.0	3.2	4.4	5.7	1.4	4.4	5.3	4.6	13.6	3.8	8.1	7.5
KIR2DL1	"47.11, CD158A, cl-42, nkat1, p58.1"	ENSG00000125498	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1"	P43626	19	54769811-54784322	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5"	"Cell line enriched"	"Detected in single"	25	"U-266/84: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"																				"unprognostic (2.14e-1)"	"unprognostic (9.82e-2)"		"unprognostic (8.18e-2)"		"unprognostic (2.19e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.11e-2)"	"unprognostic (6.87e-2)"		"unprognostic (1.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.61e-2)"		0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.0	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	2.2	4.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.8	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	4.5	0.4	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
KIR2DL3	"CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58"	ENSG00000243772	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3"	P43628	19	54738515-54753052	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 3.0;lymphoid tissue: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.37e-2)"	"unprognostic (2.35e-2)"		"unprognostic (2.23e-1)"		"unprognostic (6.88e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.41e-2)"		"unprognostic (2.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-2)"	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.1	2.1	0.1	0.1	0.2	0.1	2.2	0.0	0.0	0.1	0.4	3.0	2.4	0.0	0.0	1.0	0.1	0.1	0.0	0.8	0.1	1.3	0.1	1.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	5.6	0.1	0.1	0.8	0.6	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.1;lung: 6.8"	"Cell line enhanced"	"Detected in some"		"HEL: 16.8;HMC-1: 5.5;K-562: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA005470: AB_2134886, HPA076575: AB_2732315"	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	1.2	0.8	0.7	0.3	2.3	0.9	0.4	2.5	2.4	1.2	3.8	0.7	0.2	0.6	0.5	0.3	4.6	0.2	0.9	0.7	1.1	2.8	0.4	0.2	6.8	0.4	1.3	1.3	1.3	0.2	0.1	1.7	0.2	2.2	0.6	2.8	2.5	1.1	0.9	1.0	2.6	1.1	1.9	1.8	0.2	2.2	1.8	0.9	0.2	1.2	1.7	1.2	1.8	2.9	0.3	0.2	7.1	0.2	1.1	1.8	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.1	2.4	0.3	0.0	0.0	0.3	16.8	1.7	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.3	3.8	0.0	1.2	0.0	0.2	0.3	0.4	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	1.5	0.7	0.0	0.0	2.8	0.0	0.4	7.1	0.2	0.9	1.0	0.2	0.8	0.2	0.4	1.8	0.1	0.3	0.1	1.0	1.1	1.1	0.2	0.2	0.6	0.7	0.7	2.3	2.5	2.4	1.1	2.8	1.3	1.3	2.2	0.9
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552613	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.8;lung: 28.5;stomach 1: 27.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 37.3;RPTEC TERT1: 18.9;T-47d: 8.9;U-266/84: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA049079	Approved				"Secreted to blood"					"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favourable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favourable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.5	0.5	5.1	1.2	0.0	2.1	0.3	1.4	2.5	20.4	0.6	3.1	6.2	0.2	5.1	12.9	0.5	16.5	0.6	0.4	0.7	8.5	0.5	28.5	0.0	0.3	0.0	0.7	13.6	0.0	2.1	0.9	1.8	10.7	21.9	2.1	15.7	3.0	0.3	6.1	28.8	1.6	0.3	0.5	27.0	6.2	0.0	0.2	0.4	4.1	14.9	8.8	5.0	0.9	0.4	2.4	0.9	0.6	0.7	1.7	5.0	6.7	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.6	37.3	0.0	3.8	0.1	1.8	2.8	0.0	0.2	0.0	0.8	0.9	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	0.3	0.5	0.0	0.0	0.4	18.9	4.6	0.0	0.0	0.5	6.2	0.1	8.9	0.1	0.0	0.0	0.5	0.0	0.1	0.6	8.9	0.0	0.0	0.0	0.0	2.2	0.9	0.4	0.5	0.2	0.3	0.4	0.5	0.4	0.2	0.9	0.7	0.6	2.4	0.6	0.4	0.4	0.3	1.7	0.5	1.2	0.3	1.4	0.4	0.7	0.3	0.0	1.8	0.0
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.2	0.3	0.5	34.2	7.7	0.4	0.4	0.3	1.1	0.9	6.7	32.9	0.2	5.7	0.6	0.2	0.2	16.2	13.9	1.6	4.8	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.4	3.6	1.2	0.0	4.2	6.3	2.6	12.0	22.9	12.0	0.5	4.9	1.3	2.7	4.3	4.2	6.1	5.5	1.8	2.6	2.6	3.8	0.6	7.5	2.3	2.7	4.3	4.1	1.5	1.4	2.8	2.0	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 15.1"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;NB-4: 10.3;RH-30: 5.0;THP-1: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 8.3;plasmacytoid DC: 7.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 7.0;T-cells: 8.3"	"Low region specificity"	"Detected in many"							HPA059545	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA059545: AB_2684057"	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	1.0	0.5	0.5	5.1	1.6	3.1	0.5	2.0	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2.0	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1.0	0.5	1.0	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2.0	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.6	0.9	1.3	2.4	0.0	0.0	0.1	0.7	0.0	2.9	0.0	0.4	0.2	1.4	5.3	0.0	0.0	2.3	0.0	0.0	0.4	0.4	0.0	0.1	0.0	2.0	0.0	2.0	0.0	0.0	10.3	0.4	0.2	0.2	5.0	0.1	0.0	0.0	0.5	3.3	0.1	0.2	0.0	0.2	15.8	0.0	0.0	0.2	0.2	0.0	0.4	0.2	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.0	8.3	0.7	0.5	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.2	0.5	1.6	2.0	3.2	0.5	0.1	0.5	0.5	0.5	0.8
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Cell line enriched"	"Detected in single"	111	"HEL: 22.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Cell line enriched"	"Detected in single"	138	"HEL: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"									HPA008053	Uncertain					12000000	12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390749-113685923	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 50.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007923, HPA008444"	Approved		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA007923: AB_1853503, HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favourable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	4.4	4.3	9.5	9.0	6.2	0.4	11.6	11.3	11.9	4.9	15.3	1.3	1.7	7.4	6.2	8.7	10.0	4.8	6.3	4.2	6.6	9.5	9.6	8.0	50.7	2.6	8.0	7.9	8.0	13.3	7.1	8.2	9.2	5.2	5.5	10.5	5.9	7.8	3.6	2.4	3.1	25.1	5.9	5.4	3.6	14.6	4.9	3.9	3.9	16.5	9.1	9.0	4.5	9.8	0.1	0.7	1.1	0.2	0.8	1.8	0.2	8.3	9.7	9.2	4.1	4.3	6.3	2.7	5.9	2.7	4.5	5.1	8.5	2.5	0.4	4.4	5.2	3.7	8.3	4.4	5.6	9.0	8.9	3.6	8.4	3.9	1.0	2.9	5.4	3.3	2.2	4.7	10.5	6.2	4.5	7.9	6.1	5.4	4.7	0.8	3.4	6.0	6.8	14.8	1.0	5.3	3.7	8.5	8.8	6.8	11.6	2.0	6.0	1.5	10.8	7.4	9.4	6.8	8.1	3.2	2.6	0.0	3.9	1.5	5.9	0.4	0.2	0.0	0.5	0.0	0.5	0.0	1.3	0.2	0.7	0.1	1.8	0.1	1.1	0.8	0.2	0.2	0.0	0.2	9.5	6.2	11.3	11.9	6.6	9.5	8.0	7.9	5.2	3.9
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116566	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 107.7;intestine: 142.1;lung: 72.9"	"Cell line enhanced"	"Detected in some"		"A-431: 40.0;A549: 39.2;CAPAN-2: 54.2;fHDF/TERT166: 59.5;HaCaT: 42.2;PC-3: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Low region specificity"	"Detected in single"							HPA051410	Uncertain									"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	5.5	1.0	0.9	11.1	2.1	0.1	7.7	0.4	1.1	22.5	46.4	0.2	1.3	41.2	6.0	2.7	107.7	2.8	6.7	10.8	1.7	1.0	1.9	1.1	72.9	3.7	1.1	0.2	1.6	2.9	49.8	1.0	3.7	3.6	5.5	19.0	1.6	11.2	1.5	2.1	11.1	142.1	5.1	4.2	2.0	1.8	2.2	0.4	0.6	5.6	45.8	63.8	7.8	35.4	0.9	0.7	9.3	0.7	2.1	1.0	0.5	40.0	39.2	0.0	0.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	6.4	54.2	0.1	19.7	59.5	42.2	0.0	2.3	0.0	0.1	0.0	0.3	1.1	0.0	0.3	0.0	0.1	0.9	2.1	0.1	0.0	19.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	23.9	0.0	0.0	0.1	5.1	2.2	0.1	0.0	0.0	1.4	0.1	0.0	0.2	19.9	0.0	0.1	0.1	0.1	0.0	0.0	4.6	0.0	0.0	0.0	9.3	0.7	1.0	0.4	0.4	0.4	0.7	0.8	0.7	0.3	0.9	0.5	1.0	4.4	2.1	0.2	0.7	0.6	0.5	0.9	2.1	0.4	1.1	1.7	1.0	1.1	0.2	3.6	0.4
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942166-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.3;lung: 65.6;lymphoid tissue: 58.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 15.8;intermediate monocyte: 26.7"	"Lineage enriched"	"Detected in many"	5	"monocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		24000000	24000000	"Golgi apparatus"	"Golgi apparatus"	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0.0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1.0	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0.0	3.0	0.5	0.4	8.8	1.1	0.0	5.0	0.3	26.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.6	0.0	0.0	6.0	0.9	0.0	3.6	0.0	0.2	0.0	1.3	0.0	0.0	15.8	0.0	0.0	26.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	3.2	0.4	0.0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1, cartilage matrix protein"	P21941	1	30711277-30723587	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 6.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Karpas-707: 3.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.0;T-cells: 2.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA028580	Supported				"Secreted to extracellular matrix"					"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"	0.4	0.4	1.1	1.0	0.7	2.6	0.4	0.4	1.7	2.0	0.4	0.4	0.4	0.3	1.7	0.6	0.4	0.9	0.7	0.4	1.2	1.1	0.4	0.4	6.6	2.0	1.1	0.4	2.9	0.6	0.0	1.1	1.1	0.4	0.5	0.0	0.4	1.4	0.4	0.4	0.9	0.5	0.4	1.4	1.4	0.5	1.0	0.4	0.4	1.4	0.4	0.4	0.5	1.2	3.0	0.1	0.2	0.1	0.0	2.3	0.6	0.9	0.5	0.2	0.9	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.1	1.4	0.7	3.4	0.1	1.3	0.2	0.1	0.2	1.5	0.4	1.3	1.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.9	0.0	1.9	3.4	0.0	1.4	0.1	0.2	0.2	1.0	0.5	1.4	0.5	0.0	0.4	0.4	0.6	0.5	0.4	0.7	0.4	1.2	0.6	0.3	0.8	0.2	0.8	0.8	0.1	0.3	0.0	0.6	2.0	0.0	0.1	0.0	0.5	0.0	0.9	0.9	0.6	0.5	0.0	3.0	2.3	1.2	0.2	0.0	0.0	0.1	0.8	0.6	1.1	0.7	0.4	1.7	1.2	1.1	1.1	0.4	0.4	0.4
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Cell line enriched"	"Detected in many"	6	"Hep G2: 55.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.9;hypothalamus: 3.2"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"			"Endoplasmic reticulum, Golgi apparatus"	"Endoplasmic reticulum, Golgi apparatus"	"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	1.9	6.4	0.0	1.8	4.0	0.4	0.7	0.4	2.6	3.3	1.8	1.0	0.0	0.3	0.6	0.4	0.1	4.9	3.7	0.0	0.1	0.0	0.4	55.1	0.4	0.0	0.0	8.7	0.3	2.8	0.6	3.4	0.0	0.0	5.4	0.9	0.0	0.0	1.9	0.9	0.0	0.0	0.0	7.8	1.7	0.0	0.8	4.1	0.7	2.4	7.6	0.0	1.9	3.8	4.7	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	5	"HaCaT: 19.1;PC-3: 7.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	7.2	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809344-17911170	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 44.8;lymphoid tissue: 37.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 17.2;TIME: 16.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	15	"myeloid DC: 8.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA004114, HPA045134, CAB068203"	Enhanced					130000000	130000000			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	34.8	8.3	0.3	6.2	1.2	0.0	19.8	0.7	0.6	5.2	11.2	0.6	0.9	2.2	4.5	10.4	4.2	1.3	7.9	13.4	0.9		12.4	16.4	44.8	37.8	1.0	0.0	3.6	5.1	1.8	2.4	15.4	3.1	5.5	5.1	7.0	0.7	1.9	5.1	0.0	6.5	8.2	1.4	30.6	2.2	7.1	0.8	0.8	6.5	3.5	0.7	7.5	5.1	0.0	8.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2										
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	14000000	14000000	Vesicles	Vesicles	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.4	102.3	0.0	15.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.2	1.1	0.9	0.0	0.0	0.0	22.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Group enriched"	"Detected in many"	7	"CAPAN-2: 139.8;RPTEC TERT1: 107.3;T-47d: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	4900000	4900000	"Plasma membrane"	"Plasma membrane"	"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.5	0.7	1.9	0.0	139.8	0.0	10.2	1.1	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	0.2	0.2	0.0	3.4	107.3	0.1	0.6	0.2	3.4	5.9	0.1	47.1	0.6	0.2	0.4	0.8	1.3	0.1	2.2	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell line enriched"	"Detected in some"	6	"AF22: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoli	Nucleoli	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	31.7	0.0	0.0	0.3	0.1	0.5	5.6	0.5	0.5	0.0	0.0	2.4	0.0	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	0.3	2.6	3.0	0.4	0.5	0.0	0.0	0.9	0.3	0.0	0.0	0.7	1.0	0.3	0.0	1.2	0.7	0.7	0.1	1.0	0.0	1.1	1.6	0.5	0.0	1.6	0.2	0.2	4.6	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906150-54916140	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.5;lymphoid tissue: 13.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049311			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	1.4	0.2	0.1	3.7	0.4	2.1	0.3	0.1	0.3	0.3	2.1	0.0	0.5	0.1	1.2	1.3	0.3	0.2	2.1	1.9	0.2	0.2	0.3	2.5	5.5	3.8	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.6	0.2	1.0	0.4	0.1	0.3	0.5	3.4	1.2	0.2	13.9	0.3	0.4	0.0	2.0	0.3	0.1	2.6	0.7	0.3	0.2	0.2	1.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.7;U-266/70: 10.1;U-266/84: 38.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.1	0.0	6.8	5.6	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.1	0.2	10.1	38.7	0.0	1.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8
NKD2	Naked2	ENSG00000145506	"Naked cuticle homolog 2"	Q969F2	5	1008829-1038943	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;HEK 293: 5.4;NB-4: 11.4;RPMI-8226: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049463	Uncertain									"HPA049463: AB_2680777"	"unprognostic (6.23e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.87e-3)"	"unprognostic (4.43e-1)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-1)"	2.6	3.0	1.6	1.7	2.3	0.8	2.6	0.3	5.2	1.5	2.2	0.8	1.9	1.5	0.9	1.2	5.1	2.3	4.4	5.7	2.7	1.0	3.7	1.9	25.1	9.8	0.9	2.0	2.2	3.6	0.7	1.2	3.1	3.4	3.9	0.9	1.6	4.4	1.6	0.9	10.4	2.4	2.8	1.2	9.8	1.3	4.7	0.6	13.3	1.3	0.9	3.7	1.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	0.0	0.0	12.2	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	3.6	11.4	0.5	0.0	4.1	0.0	27.5	0.0	2.2	0.4	0.2	0.1	0.0	0.7	0.1	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.3	0.3	5.2	2.7	1.0	0.9	2.0	3.4	0.6
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in some"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	9.7	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5
NOTCH4	INT3	ENSG00000204301	"Notch 4"	Q99466	6	32194843-32224067	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.3;lung: 26.2"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									820000	820000				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	31.3	3.5	3.6	2.9	6.3	1.5	16.7	2.5	8.2	3.4	5.9	1.3	3.3	3.2	5.8	12.1	3.7	4.0	2.7	10.5	4.2	2.1	6.1	5.0	26.2	2.6	4.9	1.1	2.5	3.4	1.5	2.9	6.0	5.5	4.6	2.0	3.7	1.9	4.3	8.5	4.1	2.7	1.5	4.8	3.4	3.6	2.0	5.1	0.0	9.3	4.3	2.0	3.3	12.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.6	6.3	2.5	8.2	4.2	2.1	4.9	1.1	5.5	5.1
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"					"Low region specificity"	"Detected in all"			HPA050798			Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.4	3.1	0.5	1.9	0.7	32.0	0.0	0.3	0.0	4.1	16.8	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	33.8	0.0	0.0	0.2	15.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	64.4	25.6	0.0	7.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5
OR8G5	"OR8G5P, OR8G6"	ENSG00000255298	"Olfactory receptor family 8 subfamily G member 5"	Q8NG78	11	124256376-124266218	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.2;lung: 4.0;testis: 7.8"	"Group enriched"	"Detected in some"	4	"K-562: 5.0;PC-3: 3.1;T-47d: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.48e-1)"			5.2	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.1	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OVCH1	OVCH	ENSG00000187950	"Ovochymase 1"	Q7RTY7	12	29412474-29497686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 9.5;testis: 4.6"	"Cell line enriched"	"Detected in some"	5	"Daudi: 10.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"								"Secreted in female reproductive system"						"unprognostic (3.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	0.6	0.4	0.0	0.4	0.3	0.1	0.5	0.0	0.1	0.4	0.2			0.0	0.2	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.2	0.3	9.5	0.2	0.1		0.3	0.0	0.0	0.6	0.0		0.1	0.3		0.0	0.0	0.3	0.5	0.1	0.0	0.2	1.9	0.2	4.6			2.1		0.0	0.1	0.2	0.5	0.2	1.3	0.5	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.3	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.8	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.2	0.0	0.3										
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell line enhanced"	"Detected in some"		"A-431: 28.4;HaCaT: 38.1;HeLa: 33.2;RPTEC TERT1: 18.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	300000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	6.3	0.9	0.0	2.1	1.4	0.0	0.0	0.0	0.0	0.0	13.2	4.5	0.0	5.2	2.5	38.1	1.1	11.6	0.0	0.0	0.0	0.0	33.2	9.2	0.7	0.0	0.0	2.2	8.6	8.4	6.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.4	0.6	0.0	0.0	0.3	18.8	0.0	0.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.6;HUVEC TERT2: 4.3;PC-3: 4.7;TIME: 4.8;U-87 MG: 10.3;WM-115: 4.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.1	0.0	5.6	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.3	4.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	4.7	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.4	0.8	2.8	0.0	4.8	1.0	0.1	0.6	0.8	0.0	0.0	0.0	10.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3
PIH1D3	"CXorf41, MGC35261, NYSAR97"	ENSG00000080572	"PIH1 domain containing 3"	Q9NQM4	X	107206632-107244243	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.0"	"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"							"Region enhanced"	"Detected in single"		"midbrain: 4.6"	HPA072496	Enhanced									"HPA072496: AB_2732202"	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.1	0.9	0.0	4.0	0.2	0.0	0.0	0.1	1.3	0.0	1.9	1.0	0.1	0.5	4.5	0.1	16.2	0.1	0.1	1.6	1.5	0.2	0.0	7.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	13.9	1.3	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.3	2.1	0.3	0.6	0.2	0.2	0.3	0.9	0.1	0.0	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.2	0.9	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.3	1.7	2.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.2	1.2	0.6	0.2	0.3	0.1	0.2	0.9	4.0	0.0	0.0	1.6	1.5	0.0	0.0	8.0	1.3
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Group enriched"	"Detected in some"	8	"T-47d: 6.3;U-266/70: 16.7;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain									"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	6.3	0.0	0.0	0.0	0.9	0.0	0.0	16.7	6.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell line enriched"	"Detected in some"	4	"RT4: 13.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA042713: , HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	13.2	0.7	0.1	0.0	1.4	0.0	1.4	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRRT1B	IFITMD8	ENSG00000283526	"Proline rich transmembrane protein 1B"		9	131545514-131558620	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.0;lung: 16.0;pancreas: 7.6"	"Group enriched"	"Detected in some"	10	"A549: 15.6;BEWO: 10.4;MCF7: 4.1;T-47d: 7.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.5	4.7	0.0	0.0	0.3	0.6	1.0	0.0	9.0	3.9	0.0	0.0		1.3	6.1	16.0	0.0	0.0	0.0	1.7	7.6	1.7	0.0	0.1	0.1	3.4	2.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
PTGIR	IP	ENSG00000160013	"Prostaglandin I2 receptor"	P43119	19	46620468-46625118	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.7;lung: 35.1"	"Cell line enhanced"	"Detected in some"		"BJ: 8.3;BJ hTERT+: 9.5;fHDF/TERT166: 11.7;HDLM-2: 5.8;HEL: 21.5;HHSteC: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	10	"classical monocyte: 12.6;intermediate monocyte: 27.7;myeloid DC: 9.1;non-classical monocyte: 15.5"	"Group enriched"	"Detected in many"	12	"dendritic cells: 9.1;monocytes: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (3.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.45e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (2.09e-8)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.66e-2)"	7.8	6.3	0.4	8.0	0.6	3.8	3.0	0.1	0.6	6.5	6.0	1.2	1.4	2.7	5.0	2.7	4.5	2.7	6.4	16.0	0.6	0.3	9.0	9.6	35.1	6.5	0.8	0.7	6.9	3.5	0.1	1.2	6.3	1.1	3.2	1.4	3.3	2.5	1.3	12.2	3.0	3.7	4.1	0.5	11.3	4.5	1.6	0.8	3.5	14.5	3.4	4.3	10.2	6.5	0.5	9.1	0.5	27.7	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.1	4.5	0.0	8.3	9.5	1.2	3.4	0.0	0.0	0.0	0.7	11.7	0.0	0.0	0.0	0.7	5.8	0.0	21.5	0.0	0.0	5.8	0.0	0.0	1.4	0.0	3.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	1.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.0	12.6	0.0	0.0	27.7	0.2	0.5	0.1	0.0	9.1	0.3	1.5	0.0	0.5	0.0	15.5	0.8	1.4	7.2	0.4	0.6	0.1	0.6	0.6	0.3	0.8	0.7	1.1	0.8
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	390000	390000	Nucleoplasm	Nucleoplasm	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	8.8	0.0	1.7	15.0	0.3	0.2	78.9	0.0	0.3	10.9	0.1	25.7	0.2	1.0	0.2	0.3	0.5	0.1	2.6	1.2	0.0	1.9	0.8	0.8	0.9	0.3	1.1	1.7	0.3	11.0	9.0	1.9	0.0	0.2	0.0	5.7	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	4.9	6.0	0.0	0.9	0.5	0.1	0.0	0.0	27.0	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	9.3	19.3	0.2	1.7	0.0	0.0	0.0	13.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	2.3	1.5	0.1	1.8	0.0	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002264	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;lung: 12.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 3.2;fHDF/TERT166: 3.4;NTERA-2: 8.9;SK-BR-3: 6.1;U-2 OS: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	HPA048887	Uncertain				"Secreted in other tissues"					"HPA048887: AB_2680545"	"unprognostic (2.36e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (2.98e-6)"	"unprognostic (8.93e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.68e-9)"	"unprognostic (6.65e-3)"	"unprognostic (4.41e-2)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	1.0	0.8	2.0	1.7	6.2	0.2	1.7	0.5	2.4	2.0	0.3	1.6	0.0	0.7	0.3	4.2	2.3	3.1	1.5	1.1	2.8	9.0	0.3	0.5	12.0	0.4	4.5	0.8	0.4	0.4	0.4	1.7	0.9	17.5	0.6	0.3	3.7	0.3	0.9	0.2	3.1	0.4	1.8	2.0	0.3	0.5	3.4	1.4	0.0	5.4	0.6	1.3	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.6	0.0	0.1	0.0	0.0	0.0	1.1	3.2	3.4	0.1	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.1	0.1	0.0	0.0	10.5	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.5	1.6	2.8	9.0	4.5	0.8	17.5	1.4
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 6.6;lymphoid tissue: 5.1"	"Cell line enriched"	"Detected in some"	13	"Karpas-707: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037980	Uncertain									"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"	0.3	0.4	0.6	2.2	1.9	1.8	0.3	0.3	1.0	0.3	0.4	0.3	0.3	1.9	0.3	0.3	0.9	0.4	1.2	0.3	3.1	0.3	0.5	0.3	6.6	2.8	0.4	0.3	0.3	0.3	0.0	0.4	0.3	0.3	2.6	1.5	0.3	1.4	0.3	0.3	0.7	1.8	0.3	0.3	5.1	1.5	0.3	0.3	1.1	0.3	0.3	2.2	0.6	0.6	0.0	1.9	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.6	1.9	0.3	1.0	3.1	0.3	0.4	0.3	0.3	0.3
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166494326	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 51.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.8;SH-SY5Y: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA072715	Approved									"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.9	6.0	1.0	10.4	0.7	0.0	2.9	0.3	0.7	16.2	23.3	0.0	13.0	2.0	24.6	8.1	28.1	7.8	6.8	16.0	0.7	3.6	1.8	1.3	51.9	1.6	3.6	0.5	33.3	3.1	0.3	1.1	8.1	2.6	18.4	6.1	14.0	4.9	11.3	3.7	1.5	6.2	10.5	4.3	5.5	6.4	6.9	0.1	0.5	1.3	4.9	0.2	9.7	7.6	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.1	0.1	0.8	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.7	0.3	0.7	0.7	3.6	3.6	0.5	2.6	0.1
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced									"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favourable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	9.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.4	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Cell line enhanced"	"Detected in some"		"HEL: 3.7;HMC-1: 3.6;NB-4: 3.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.8"	HPA029590	Uncertain									"HPA029590: AB_10794613"	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	0.9	2.1	0.2	0.2	0.0	0.8	0.0	0.0	0.0	0.7	0.1	3.7	0.6	0.7	0.1	0.0	3.6	0.3	0.1	0.0	0.2	0.0	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.3	1.0	0.2	0.7	0.4	0.2	0.0	0.3	0.3	0.6	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.6;HL-60: 32.5;Karpas-707: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved									"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favourable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favourable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.4	5.4	1.2	0.0	4.5	10.4	2.8	0.6	44.6	1.6	2.7	0.2	20.2	5.3	5.9	0.1	0.3	3.8	1.2	0.9	9.1	11.0	13.8	11.4	0.1	1.8	32.5	4.7	5.5	1.4	0.8	2.6	0.6	13.8	48.4	8.6	3.6	11.7	15.2	3.6	5.3	3.0	0.0	17.3	9.4	2.0	1.6	4.0	15.2	0.2	1.4	3.7	12.1	3.1	5.4	2.0	11.0	8.6	21.7	9.0	25.1	8.9	21.2	4.9	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 5.4;Hep G2: 14.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.4	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702228-66782848	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.8;HaCaT: 12.3;HeLa: 17.1;U-2197: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (5.45e-5)"	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3.0	2.0	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8.0	1.7	2.0	0.0	16.7	0.6	0.8	6.8	7.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.8	6.9	1.1	2.4	4.3	1.1	6.5	4.9	0.1	0.8	0.0	1.3	3.1	0.5	20.8	4.1	12.3	1.5	0.0	0.1	1.5	5.7	10.7	17.1	1.1	0.5	0.0	0.8	1.4	0.0	0.0	0.0	0.9	0.9	0.7	0.3	1.3	0.1	2.9	2.1	2.6	0.0	1.2	1.4	2.3	5.4	2.5	1.1	2.6	2.9	0.5	1.0	1.9	4.2	3.0	3.9	12.1	0.9	0.3	1.2	0.2	2.1	3.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	4.6	0.8	2.8	3.0	2.0	3.6	2.3	4.5	2.0
SOX7		ENSG00000171056	"SRY-box 7"	Q9BT81	8	10723768-10730512	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 9.2;hTCEpi: 17.0;HUVEC TERT2: 19.9;TIME: 5.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Nuclear speckles"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	17.4	1.8	3.5	3.4	3.3	0.7	7.0	1.7	4.2	16.0	3.4	2.1	1.0	0.8	7.1	6.8	19.7	3.0	6.1	12.5	2.6	2.2	3.0	7.4	37.2	2.9	2.6	1.5	2.6	4.5	2.7	4.2	26.4	3.6	5.8	2.2	7.6	7.1	5.0	12.5	11.7	2.1	4.2	3.0	2.2	2.2	1.9	3.2	0.6	4.7	22.7	14.5	8.8	23.1	1.9	0.3	0.8	0.4	0.2	1.2	0.1	4.4	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.2	9.2	2.7	3.3	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	17.0	0.0	3.5	19.9	0.4	0.2	0.0	0.1	0.1	0.1	1.2	2.6	0.9	0.0	0.0	0.0	1.6	0.5	2.7	1.7	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.5	0.4	0.1	0.2	0.2	1.2	1.9	0.3	0.1	0.1	0.3	0.2	0.4	0.8	0.2	0.1	0.3	0.1	0.1	3.5	3.3	1.7	4.2	2.6	2.2	2.6	1.5	3.6	3.2
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059035-72089032	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.1;brain: 70.7;lung: 52.1"	"Group enriched"	"Detected in some"	7	"Hep G2: 24.8;SCLC-21H: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	42000	42000			"HPA044605: AB_10965991"	"prognostic favourable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favourable (4.72e-4)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	4.2	29.8	31.9	24.9	47.8	27.9	2.0	70.7	63.2	2.5	4.2	9.8	0.0	6.2	2.5	2.7	2.8	4.7	9.9	4.7	27.5	49.5	18.8	2.5	52.1	36.4	36.0	32.1	3.7	1.5	1.7	12.8	2.9	47.9	3.0	4.1	5.4	2.8	4.5	3.6	1.9	9.3	3.4	22.3	16.9	8.3	13.6	9.2	43.4	3.3	0.6	27.0	8.0	1.4	5.6	0.7	2.9	0.2	2.8	47.1	10.3	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.1	0.6	24.8	0.8	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	35.3	2.1	0.0	0.7	0.2	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.4	0.8	3.7	0.1	0.0	0.1	0.0	0.1	0.0	27.5	0.2	47.1	5.6	27.7	21.9	0.0	4.5	21.5	21.2	2.9	2.8	0.0	0.7	37.5	10.3	31.9	47.8	70.7	42.0	27.5	49.5	36.0	32.1	47.9	9.2
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17318383-17454330	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 105.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	1.8	0.9	3.1	1.0	5.0	4.0	14.4	2.5	3.4	1.1	1.7	3.3	0.4	1.0	1.6	10.4	2.4	1.3	1.9	9.1	3.7	4.4	2.5	2.4	17.5	0.8	8.8	1.7	1.1	0.5	0.3	1.3	3.5	5.5	4.3	1.8	13.7	1.9	0.6	2.0	2.8	1.3	1.3	4.3	1.5	1.0	1.2	2.5	0.0	1.8	0.5	2.0	1.1	3.9	0.9	0.7	3.8	1.4	2.1	5.6	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.1	0.0	0.0	105.7	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	1.2	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	1.3	2.5	0.4	0.5	0.3	1.2	1.4	0.7	0.9	1.0	1.7	2.9	2.1	0.7	0.6	5.6	0.9	3.1	5.0	2.5	3.4	3.7	4.4	8.8	1.7	5.5	2.5
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell line enriched"	"Detected in single"	39	"AF22: 18.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1
SUSD2	"BK65A6.2, FLJ22778"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181259-24189110	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 100.1"	"Cell line enriched"	"Detected in some"	31	"SK-BR-3: 135.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA004117	Enhanced		Approved	"Plasma membrane"		3600000	3600000	"Plasma membrane"	"Plasma membrane"	"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	6.0	4.2	0.3	1.4	0.9	0.5	11.3	3.8	1.4	10.5	10.5	2.5	1.3	7.8	7.1	8.3	2.8	6.9	5.3	10.8	0.6	2.9	19.5	1.2	100.1	1.4	0.6	2.6	2.6	2.4	1.3	3.6	3.5	9.6	2.8	1.0	2.2	7.9	4.0	3.0	11.8	32.4	2.4	3.0	1.6	2.5	1.9	0.7	0.1	12.7	5.9	1.5	2.3	4.7	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.7	1.5	0.0	0.0	2.9	3.8	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.2	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.2	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.1	135.7	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.8	1.4	0.6	2.9	0.6	2.6	9.6	0.7
TBX5	HOS	ENSG00000089225	"T-box 5"	Q99593	12	114353931-114408442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.5;lung: 14.0;placenta: 19.7"	"Cell line enhanced"	"Detected in some"		"BJ: 12.8;BJ hTERT+: 28.6;BJ hTERT+ SV40 Large T+: 6.6;BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HAP1: 11.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	2.2	0.1	0.1	0.0	0.1	0.0	3.8	0.8	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	6.4	0.1	0.0	44.5	2.2	0.1	0.1	0.1	14.0	1.6	0.1	0.1	0.1	0.1	0.0	0.1	19.7	0.5	5.4	0.0	1.4	0.1	0.0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	6.5	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.8	28.6	6.6	8.1	0.0	0.0	0.0	0.0	0.7	0.0	11.2	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0.0
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889138-133895553	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lung: 74.4;ovary: 61.6"	"Cell line enriched"	"Detected in some"	12	"HHSteC: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013189	Uncertain									"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	4.7	2.2	0.2	11.6	0.5	0.0	0.4	0.2	0.2	12.7	16.8	0.4	9.6	5.2	12.9	9.6	19.1	2.2	14.6	13.2	0.2	0.2	17.0	4.1	74.4	1.0	0.2	0.0	61.6	1.9	0.0	2.4	48.4	1.2	57.8	5.3	0.0	0.2	16.0	0.8	0.3	13.9	21.1	0.2	52.2	5.7	5.9	0.0	0.0	0.5	0.0	0.0	19.6	24.6	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.0	1.2	0.0
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 52.8;lung: 99.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;ASC TERT1: 12.0;HHSteC: 27.4;HSkMC: 12.6;U-87 MG: 8.3;WM-115: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favourable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	24.7	2.0	3.4	1.5	3.9	0.0	52.8	0.7	5.3	5.1	10.5	0.7	8.8	2.7	1.6	16.7	4.6	3.6	4.8	5.8	1.6	2.8	1.2	5.8	99.5	1.5	3.4	0.6	10.1	1.9	0.0	3.3	23.5	2.6	7.4	5.1	2.6	2.2	11.7	7.0	1.3	6.6	5.2	1.4	2.3	10.7	3.9	0.6	0.5	3.8	3.7	1.3	5.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	17.7	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	27.4	0.0	0.0	12.6	0.0	0.8	0.1	0.0	0.5	0.1	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.3	0.0	0.5	0.0	0.1	8.3	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.7	1.7	1.6	2.8	3.4	0.6	2.6	0.6
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.0	2.5	2.8	3.0	0.8	0.4	5.4	2.9	0.9	1.1	1.2	2.0	3.2	5.3	3.6	1.4	2.8	1.7	1.3	2.5	7.0	2.7	6.3	6.4	2.6	0.5	3.6	5.3	1.1	1.5	1.4	1.1	1.3	4.4	8.5	0.9	2.6	3.2	4.0	4.8	2.6	2.7	4.4	4.4	1.1	3.1	3.3	3.2	4.0	3.0	2.2	3.6	3.3	6.5	4.5	4.9	7.1	3.1	5.0	4.0	3.5	2.3	3.3	2.3	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15a"	P0CG34	X	102513676-102516784	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.1;prostate: 17.3"	"Cell line enhanced"	"Detected in some"		"AF22: 98.8;NTERA-2: 25.5;RH-30: 44.9;SH-SY5Y: 25.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 56.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"NK-cell: 2.5;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.1;NK-cells: 2.5"																				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.6	1.0	1.9	1.0	2.2	0.7	5.1	3.4	2.6	4.9	0.8	0.7	2.7	0.3	5.4	1.3	0.9	1.4	1.5	2.2	1.9	1.4	2.7	0.2	16.1	3.8	1.6	0.7	6.1	0.8	0.0	1.0	1.8	1.9	17.3	1.0	0.7	4.0	1.6	1.2	0.5	0.7	2.3	1.7	0.6	0.5	4.7	1.8	7.8	6.1	0.9	2.6	0.9	6.0	0.1	1.1	0.0	0.0	2.5	0.1	1.1	0.0	0.0	98.8	18.4	0.4	0.0	0.0	2.1	0.1	0.2	0.8	0.0	0.1	0.0	0.2	0.3	0.0	18.5	0.1	0.2	0.0	0.9	1.7	0.3	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	1.1	0.1	0.0	6.9	0.0	18.5	0.0	25.5	0.2	0.0	44.9	0.0	1.9	0.0	16.9	25.7	2.3	0.1	0.0	0.2	0.5	0.4	0.0	11.1	0.2	1.7	2.0	0.3	0.0	1.1	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	1.1	0.0	1.1	1.9	2.2	3.4	2.2	1.9	1.4	1.6	0.7	1.9	1.8
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696651-63698684	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.4;lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 11.4;RPTEC TERT1: 45.0;TIME: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 17.4"					"Low region specificity"	"Detected in many"			HPA047154	Approved				"Secreted to blood"					"HPA047154: AB_2679959"																		11.8	2.0	10.0	39.2	17.6	2.5	7.0	5.4	8.1	4.5	6.0	2.1	0.0	2.0	3.0	2.0	6.6	2.5	3.6	2.0	11.6	6.6	4.4	2.5	39.4	9.8	5.9	0.0	3.6	2.2	2.0	4.2	2.1	23.6	2.7	2.3	0.0	2.9	2.0	10.0	4.8	3.8	4.6	13.0	56.3	10.0	2.1	5.3	2.7	6.5	3.3	12.1	11.6	2.3	0.0	17.4	0.0	0.9	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	27.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.9	17.4	0.0	0.1	10.0	17.6	5.4	8.1	11.6	6.6	5.9	0.0	23.6	5.3
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;lung: 8.5;lymphoid tissue: 15.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.6;hTEC/SVTERT24-B: 6.4;U-138 MG: 24.9;U-266/70: 7.0;U-266/84: 6.9;U-87 MG: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.2"					"Low region specificity"	"Detected in all"			HPA043063	Uncertain									"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	2.2	0.3	1.0	9.8	0.2	1.3	0.3	0.3	0.7	2.0	1.3	0.2	0.2	0.6	0.2	0.2	1.8	0.4	1.5	0.4	0.4	0.6	0.3	0.7	8.5	3.5	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.5	0.9	0.4	0.2	0.8	0.2	0.4	0.3	1.2	0.5	0.3	2.8	0.8	1.4	0.2	15.4	0.4	3.6	6.3	1.3	0.4	0.2	0.1	0.7	0.2	0.1	9.2	0.8	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.9	0.1	0.1	0.1	2.1	0.0	0.0	0.5	0.8	5.6	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	6.4	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	24.9	0.5	2.0	0.1	7.0	6.9	0.2	5.1	0.2	0.8	0.7	0.2	0.0	4.0	0.0	2.7	0.1	1.8	9.2	0.0	0.2	0.8	4.4	0.6	0.1	0.2	0.1	1.1	0.8	1.0	0.2	0.3	0.7	0.4	0.6	0.7	0.2	0.5	0.2
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562"	Uncertain									"HPA037561: AB_10670384, HPA037562: AB_2675545"	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.3	0.3	1.0	0.8	0.2	0.8	3.6	2.7	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 23.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"									HPA005563	Uncertain				"Intracellular and membrane"					"HPA005563: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.6;brain: 34.8;lung: 24.6"	"Group enriched"	"Detected in some"	4	"hTCEpi: 36.5;THP-1: 20.2"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Intracellular and membrane"	19000	19000			"HPA010917: , HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	35.6	11.8	10.1	3.0	13.4	0.3	8.6	1.6	21.7	5.9	2.9	24.1	0.0	0.9	1.5	2.1	0.6	6.5	8.4	1.7	10.4	9.5	1.0	2.1	24.6	1.7	21.7	5.2	2.7	2.5	2.7	2.9	8.8	13.4	1.8	3.9	2.1	4.4	3.0	0.8	0.4	1.2	3.8	34.8	0.5	2.2	0.8	12.9	0.0	1.6	0.8	0.5	4.2	0.5	0.5	4.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	36.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	10.1	13.4	1.6	8.3	10.4	9.5	21.7	5.2	13.4	12.9
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.4;BEWO: 37.5;CACO-2: 8.8;Hep G2: 24.2;NTERA-2: 33.2"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Plasma membrane, Actin filaments, Focal adhesion sites"	"Plasma membrane, Actin filaments, Focal adhesion sites"	"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	37.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	24.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	2.6	33.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC diff: 8.6;BJ hTERT+: 4.6;HEL: 4.3;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved					140000	140000			"HPA045098: "	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.6	0.2	0.0	8.6	2.1	0.0	3.0	4.6	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1
TSPAN19		ENSG00000231738	"Tetraspanin 19"	P0C672	12	85014311-85036277	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lung: 9.7;pituitary gland: 20.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.3;SK-BR-3: 4.2;U-266/70: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057066	Uncertain									"HPA057066: AB_2683325"				"unprognostic (1.94e-1)"	"unprognostic (9.81e-4)"	"unprognostic (8.57e-2)"		"unprognostic (8.37e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.09e-3)"		"unprognostic (2.22e-1)"	"unprognostic (3.78e-2)"		0.4	0.8	1.5	0.5	1.9	2.3	0.2	1.0	2.6	0.5	0.4	1.4	0.0	1.1	0.5	2.5	0.8	1.8	0.8	0.4	3.2	4.4	0.7	0.1	9.7	0.5	2.3	4.4	0.4	1.6	0.4	20.0	0.5	4.9	1.0	0.2	2.4	0.8	0.0	1.6	4.5	0.6	0.0	1.6	0.5	0.5	8.4	1.4	0.0	4.1	1.3	0.2	0.5	0.2	1.8	0.9	5.4	1.0	0.8	1.1	0.0	0.8	0.0	1.6	0.5	0.8	1.4	1.8	0.9	0.1	0.0	0.5	0.8	0.0	1.0	0.1	0.0	0.3	0.2	0.3	0.0	0.8	1.6	0.0	0.5	0.7	2.1	1.4	1.7	1.0	1.1	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.2	0.0	0.0	0.3	6.3	2.7	0.0	4.2	0.9	1.0	0.3	1.2	3.0	0.9	1.3	0.8	3.8	0.0	0.5	3.2	0.0	1.3	1.1	1.0	1.1	1.0	0.7	0.7	0.9	0.8	0.5	0.1	1.8	1.1	1.0	5.4	0.8	0.4	0.9	0.3	0.0	1.5	1.9	1.0	2.6	3.2	4.4	2.3	4.4	4.9	1.4
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.7	1.4	2.7	7.9	2.8	3.7	1.1	1.7	2.9	1.8	3.2	2.8	2.9	12.8	2.7	23.7	4.6	4.4	12.4	3.9	0.2	0.9	0.0	14.0	0.1	1.0	8.6	5.8	11.7	3.1	2.4	2.3	0.0	4.1	3.3	2.9	0.0	1.0	4.3	1.2	2.4	0.4	5.0	2.1	0.9	0.3	5.4	3.4	0.8	2.7	5.5	1.9	1.3	2.3	5.2	3.2	0.4	0.4	2.5	8.2	4.1	3.4	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"									HPA010506	Approved									"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.8	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.2	2.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345591-15384376	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;ASC TERT1: 5.9;EFO-21: 2.6;HSkMC: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA027342	Uncertain				"Secreted to blood"	340000	340000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	9.5	7.4	0.6	1.8	1.0	0.1	19.5	1.1	0.7	10.5	7.6	0.2	4.1	1.1	10.1	12.9	15.4	2.7	3.5	27.8	0.6	1.1	1.0	1.3	39.0	0.7	0.8	0.2	7.3	2.6	0.2	4.4	0.2	0.8	22.2	1.9	0.2	1.5	1.8	12.0	0.5	4.3	9.8	0.6	2.3	3.4	14.9	0.1	0.0	2.0	17.5	1.2	12.3	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.8	7.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.6	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.4	0.0	0.8	5.9	0.7	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.5	0.4	0.3	0.1	0.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.4	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.1	0.7	0.6	1.1	0.8	0.2	0.8	0.1
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.2	0.0	2.5	9.3	0.0	11.0	24.3	3.2	4.8	0.3	1.7	0.0	4.3	11.8	0.0	0.1	0.2	18.2	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	13.9	2.8	64.8	0.6	0.0	8.8	0.2	0.0	0.0	1.7	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	18.8	0.0	38.5	13.0	0.4	4.5	15.0	0.0	0.0	0.0	10.4	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 83.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.2;RT4: 19.4;SK-BR-3: 11.1;WM-115: 35.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	32	"dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5"	"Group enriched"	"Detected in many"	5	"amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved									"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	8.1	1.8	5.6	6.4	11.8	1.3	7.4	10.2	13.8	2.0	17.7	0.6	27.8	22.0	0.9	4.6	2.7	1.0	10.6	3.1	2.9	1.2	1.4	15.4	83.1	5.1	1.3	8.4	0.5	1.4	2.9	1.2	1.9	1.9	13.0	18.1	2.2	9.7	29.0	0.8	12.2	25.9	1.3	0.9	2.7	3.7	0.9	1.3	0.0	7.2	3.2	3.1	6.0	2.4	0.1	3.9	0.1	3.2	0.0	5.5	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.9	27.2	0.1	1.3	0.0	1.1	0.0	0.7	0.0	0.0	2.1	1.6	0.8	0.0	0.1	0.0	0.2	0.0	1.7	0.1	0.5	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.7	0.1	0.2	0.0	1.2	0.0	19.4	0.6	0.0	0.0	11.1	0.0	6.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	3.2	0.0	0.4	2.6	1.9	0.1	4.8	1.9	3.9	0.0	5.5	1.7	0.1	0.0	2.3	0.0	0.7	1.3	5.6	11.8	10.2	13.8	2.9	1.2	1.3	8.4	1.9	1.3
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121566	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;lung: 67.7;retina: 29.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.2;LHCN-M2: 2.4;NTERA-2: 6.8;SCLC-21H: 1.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 16.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1.0	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1.0	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1.0	3.5	0.0	0.6	3.6	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	0.0	0.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA020920: "	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0
